{"content":"<li class=\"n-box-item date-title\" data-end=\"1548478799\" data-start=\"1548392400\" data-txt=\"Monday, December 23, 2019\">Friday, January 25, 2019</li><li class=\"n-box-item sa-box-item\" data-id=\"3426222\" data-ts=\"1548456252\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ZAYO\" target=\"_blank\">ZAYO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3426222-rrd-dlng-veco-and-zayo-among-notable-after-hour-movers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">RRD, DLNG, VECO and ZAYO among notable after hour movers</a></h4><ul><li><b>Top Gainers:</b> <a href='https://seekingalpha.com/symbol/ZAYO' title='Zayo Group'>ZAYO</a> <font color=\"green\">+6.7%</font>. <a href='https://seekingalpha.com/symbol/RRD' title='R.R. Donnelley & Sons Company'>RRD</a> <font color=\"green\">+5.8%</font>. <a href='https://seekingalpha.com/symbol/CLI' title='Mack-Cali Realty Corp.'>CLI</a> <font color=\"green\">+4.7%</font>. <a href='https://seekingalpha.com/symbol/KEP' title='Korea Electric Power Corporation'>KEP</a> <font color=\"green\">+4%</font>. <a href='https://seekingalpha.com/symbol/CRVS' title='Corvus Pharmaceuticals'>CRVS</a> <font color=\"green\">+2.7%</font>.</li><li><b>Top Losers:</b> <a href='https://seekingalpha.com/symbol/DLNG' title='Dynagas LNG Partners LP'>DLNG</a> <font color=\"red\">-22.9%</font>. <a href='https://seekingalpha.com/symbol/REI' title='Ring Energy, Inc.'>REI</a> <font color=\"red\">-2.8%</font>. <a href='https://seekingalpha.com/symbol/VECO' title='Veeco Instruments Inc.'>VECO</a> <font color=\"red\">-2.5%</font>. <a href='https://seekingalpha.com/symbol/CBAY' title='CymaBay Therapeutics'>CBAY</a> <font color=\"red\">-2.3%</font>. <a href='https://seekingalpha.com/symbol/CVTI' title='Covenant Transportation Group, Inc.'>CVTI</a> <font color=\"red\">-1.8%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3426222\" data-linked=\"RRD, DLNG, VECO and ZAYO among notable after hour movers\" data-tweet=\"$ZAYO $ZAYO $RRD - RRD, DLNG, VECO and ZAYO among notable after hour movers https://seekingalpha.com/news/3426222-rrd-dlng-veco-and-zayo-among-notable-after-hour-movers?source=tweet\" data-url=\"https://seekingalpha.com/news/3426222-rrd-dlng-veco-and-zayo-among-notable-after-hour-movers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:44 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3426221\" data-ts=\"1548456184\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ASNS\" target=\"_blank\">ASNS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3426221-arsanis-files-150m-mixed-shelf\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Arsanis files $150M mixed shelf</a></h4><ul>   <li>Biotech Arsanis (NASDAQ:<a href='https://seekingalpha.com/symbol/ASNS' title='Arsanis, Inc.'>ASNS</a>) is <font color=\"red\">off 2%</font> in thin after-hours trading after it filed for a <a href=\"https://seekingalpha.com/filing/4313740\" target=\"_blank\">$150M mixed shelf registration</a>.</li>    <li>That's the maximum proposed offering price for securities that could include debt, common stock, preferred stock, units and/or warrants.</li>    <li>The company finished the regular session <font color=\"red\">down 1.3%</font> today. Its market cap is about $43.8M.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3426221\" data-linked=\"Arsanis files $150M mixed shelf\" data-tweet=\"$ASNS $XFOR - Arsanis files $150M mixed shelf https://seekingalpha.com/news/3426221-arsanis-files-150m-mixed-shelf?source=tweet\" data-url=\"https://seekingalpha.com/news/3426221-arsanis-files-150m-mixed-shelf\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:43 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3426217\" data-ts=\"1548454708\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ZAYO\" target=\"_blank\">ZAYO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3426217-zayo-jumps-8_6-on-chatter-of-alphabet-centurylink-interest\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Zayo jumps 8.6% on chatter of Alphabet, CenturyLink interest</a></h4><ul>   <li>Zayo Group (NYSE:<a href='https://seekingalpha.com/symbol/ZAYO' title='Zayo Group'>ZAYO</a>) is jumping after hours, <font color=\"green\">+8.6%</font>, on a new reheat of buyout chatter.</li>    <li>Frequently the subject of rumors about private-equity takeovers, Zayo is now seeing preliminary interest from Alphabet (<a href='https://seekingalpha.com/symbol/GOOG' title='Alphabet, Inc. Cl C'>GOOG</a>, <a href='https://seekingalpha.com/symbol/GOOGL' title='Alphabet, Inc. Cl A'>GOOGL</a>) and CenturyLink (NYSE:<a href='https://seekingalpha.com/symbol/CTL' title='CenturyLink, Inc.'>CTL</a>), Bloomberg says in headlines.</li>    <li>That preliminary interest might not result in a bid, though.</li><li>Firms including Blackstone, Stonepeak, KKR, I Squared, GTCR and Charlesbank have been linked to talk of purchasing Zayo in the low to mid $30s per share, though an IRR in the low teens is a hurdle as it's lower than most private-equity firms are accustomed to seeing.</li><li>Zayo Group closed today at $26.70.</li></ul><div class=\"tiny-share-widget\" data-id=\"3426217\" data-linked=\"Zayo jumps 8.6% on chatter of Alphabet, CenturyLink interest\" data-tweet=\"$ZAYO $ZAYO $GOOG - Zayo jumps 8.6% on chatter of Alphabet, CenturyLink interest https://seekingalpha.com/news/3426217-zayo-jumps-8_6-on-chatter-of-alphabet-centurylink-interest?source=tweet\" data-url=\"https://seekingalpha.com/news/3426217-zayo-jumps-8_6-on-chatter-of-alphabet-centurylink-interest\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:18 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>49&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3426200\" data-ts=\"1548451818\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RAD\" target=\"_blank\">RAD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3426200-rite-aid-to-reverse-split-shares\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Rite Aid to reverse split shares</a></h4><ul><li>Aimed at regaining compliance with NYSE's listing standard of a $1 minimum bid price, Rite Aid (NYSE:<a href='https://seekingalpha.com/symbol/RAD' title='Rite Aid Corporation'>RAD</a>) will <a href=\"https://seekingalpha.com/pr/17392131-rite-aid-announces-plans-reverse-stock-split\" target=\"_blank\">reverse spl</a>it its common stock either 1:10, 1:15 or 1:20 subsequent to a vote from shareholders on March 21.</li><li>A preliminary proxy statement will be filed later today.</li></ul><div class=\"tiny-share-widget\" data-id=\"3426200\" data-linked=\"Rite Aid to reverse split shares\" data-tweet=\"$RAD - Rite Aid to reverse split shares https://seekingalpha.com/news/3426200-rite-aid-to-reverse-split-shares?source=tweet\" data-url=\"https://seekingalpha.com/news/3426200-rite-aid-to-reverse-split-shares\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:30 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>467&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3426198\" data-ts=\"1548451552\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EYEN\" target=\"_blank\">EYEN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3426198-eyenovia-files-for-75m-mixed-shelf-offering-shares-down-1-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Eyenovia files for $75M mixed shelf offering; shares down 1% after hours</a></h4><ul><li>Eyenovia (NASDAQ:<a href='https://seekingalpha.com/symbol/EYEN' title='Eyenovia, Inc.'>EYEN</a>) slips <font color=\"red\">1%</font> after hours following the filing of a <a href=\"https://www.sec.gov/Archives/edgar/data/1682639/000114420419002881/tv511296-s3.htm\" target=\"_blank\">prospectus </a>for a $75M mixed shelf offering.</li></ul><div class=\"tiny-share-widget\" data-id=\"3426198\" data-linked=\"Eyenovia files for $75M mixed shelf offering; shares down 1% after hours\" data-tweet=\"$EYEN - Eyenovia files for $75M mixed shelf offering; shares down 1% after hours https://seekingalpha.com/news/3426198-eyenovia-files-for-75m-mixed-shelf-offering-shares-down-1-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3426198-eyenovia-files-for-75m-mixed-shelf-offering-shares-down-1-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:25 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3426195\" data-ts=\"1548451144\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BLPH\" target=\"_blank\">BLPH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3426195-bellerophon-closes-7m-capital-raise-shares-up-6-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bellerophon closes $7M capital raise; shares up 6% after hours</a></h4><ul><li>Bellerophon Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/BLPH' title='Bellerophon Therapeutics'>BLPH</a>) is up <font color=\"green\">6%</font> after hours following its <a href=\"https://seekingalpha.com/pr/17392107-bellerophon-announces-closing-7-million-public-offering-common-stock\" target=\"_blank\">announcement </a>that it has closed its public offering of 10M common shares at $0.70 per share yielding gross proceeds of $7M.</li><li>Underwriters have a 45-day option to buy an additional 1.5M shares.</li></ul><div class=\"tiny-share-widget\" data-id=\"3426195\" data-linked=\"Bellerophon closes $7M capital raise; shares up 6% after hours\" data-tweet=\"$BLPH - Bellerophon closes $7M capital raise; shares up 6% after hours https://seekingalpha.com/news/3426195-bellerophon-closes-7m-capital-raise-shares-up-6-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3426195-bellerophon-closes-7m-capital-raise-shares-up-6-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:19 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3426189\" data-ts=\"1548450883\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DPZ\" target=\"_blank\">DPZ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3426189-dominos-up-papa-johns-slumps-after-longbow-note\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Domino&#39;s up, Papa John&#39;s slumps after Longbow note</a></h4><ul><li>Domino's Pizza (NYSE:<a href='https://seekingalpha.com/symbol/DPZ' title='Domino&#39;s Pizza, Inc.'>DPZ</a>) closes <font color=\"green\">up 2.6%</font> and Papa John's (NASDAQ:<a href='https://seekingalpha.com/symbol/PZZA' title='Papa John&#39;s International, Inc.'>PZZA</a>) <font color=\"red\">sinks 7.8% </font>after Longbow analyst Alton Stump predicts that Domino's grabbed market share from Papa John's and Pizza Hut.</li><li>Pizza Hut parent Yum! Brands (NYSE:<a href='https://seekingalpha.com/symbol/YUM' title='Yum! Brands, Inc.'>YUM</a>) closed <font color=\"red\">down 0.2%</font>.</li><li>Longbow expects the company's $7.99 pan pizza promotion will help it beat Q4 comp sales estimates.</li><li>Cites channel checks indicate U.S. comp sales increased 7.5%-8% in the quarter, past the average estimate of 7.2%.</li><li><a href=\"https://seekingalpha.com/symbol/DPZ/earnings/analyst_ratings\" target=\"_blank\">Analyst ratings</a>.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3424256-oppenheimer-confident-dominos-pizza\" target=\"_blank\">Oppenheimer confident on Domino's Pizza</a> (Jan. 18)</li></ul><div class=\"tiny-share-widget\" data-id=\"3426189\" data-linked=\"Domino&#39;s up, Papa John&#39;s slumps after Longbow note\" data-tweet=\"$DPZ $DPZ $PZZA - Domino&#39;s up, Papa John&#39;s slumps after Longbow note https://seekingalpha.com/news/3426189-dominos-up-papa-johns-slumps-after-longbow-note?source=tweet\" data-url=\"https://seekingalpha.com/news/3426189-dominos-up-papa-johns-slumps-after-longbow-note\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:14 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3426186\" data-ts=\"1548450563\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MGI\" target=\"_blank\">MGI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3426186-moneygram-up-11-on-possible-sale\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">MoneyGram up 11% on possible sale</a></h4><ul><li>MoneyGram International (NYSE:<a href='https://seekingalpha.com/symbol/MGI' title='MoneyGram International, Inc.'>MGI</a>) was up <font color=\"green\">11%</font> on more than a 2.5x surge in volume during the regular session in apparent response to a Reuters <a href=\"https://www.reuters.com/article/us-moneygram-intl-m-a-exclusive/exclusive-moneygram-exploring-options-including-potential-sale-sources-idUSKCN1PJ2GV\" target=\"_blank\">report </a>that it is mulling strategic alternatives, including an outright sale.</li><li>The Dallas, TX-based online money transfer services provider needs to restructure more than $900M in debt that comes due next year.</li><li>Shares are up a fraction after hours.</li></ul><div class=\"tiny-share-widget\" data-id=\"3426186\" data-linked=\"MoneyGram up 11% on possible sale\" data-tweet=\"$MGI - MoneyGram up 11% on possible sale https://seekingalpha.com/news/3426186-moneygram-up-11-on-possible-sale?source=tweet\" data-url=\"https://seekingalpha.com/news/3426186-moneygram-up-11-on-possible-sale\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:09 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3426175\" data-ts=\"1548449911\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WVE\" target=\"_blank\">WVE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3426175-wave-life-sciences-down-4-on-disclosure-of-fda-action-on-huntingtons-programs\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Wave Life Sciences down 4% on disclosure of FDA action on Huntington&#39;s programs</a></h4><ul><li>Wave Life Sciences (<a href='https://seekingalpha.com/symbol/WVE' title='Wave Life Sciences'>WVE</a> <font color=\"red\">-3.8%</font>) is down on almost an 8x surge in volume. Shares have sold off <font color=\"red\">20%</font> this week due mostly to its <a href=\"https://seekingalpha.com/news/3425611-wave-life-sciences-prices-stock-offering-38-shares-10-percent-premarket\" target=\"_blank\">$150M stock offering</a>.</li><li>Another factor appears to be a <a href=\"https://www.sec.gov/Archives/edgar/data/1631574/000119312519015961/d686950d424b5.htm\" target=\"_blank\">disclosure </a>buried in the prospectus about an FDA action related to its two programs, WVE-120101 and WVE-120102, in Huntington's disease. Two Phase 1 studies were launched in the summer of 2017, each with a single-ascending dose portion and a multiple-ascending dose portion. Apparently, the FDA will not allow the studies to progress to the second stage or escalation to the highest dose in the first stage without conducting an additional preclinical study. In action, this is a partial clinical hold on the programs.</li></ul><div class=\"tiny-share-widget\" data-id=\"3426175\" data-linked=\"Wave Life Sciences down 4% on disclosure of FDA action on Huntington&#39;s programs\" data-tweet=\"$WVE - Wave Life Sciences down 4% on disclosure of FDA action on Huntington&#39;s programs https://seekingalpha.com/news/3426175-wave-life-sciences-down-4-on-disclosure-of-fda-action-on-huntingtons-programs?source=tweet\" data-url=\"https://seekingalpha.com/news/3426175-wave-life-sciences-down-4-on-disclosure-of-fda-action-on-huntingtons-programs\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:58 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3426173\" data-ts=\"1548449326\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LEA\" target=\"_blank\">LEA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3426173-baird-ups-lear-target-after-eps-beat\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Baird ups Lear target after EPS beat</a></h4><ul><li>Baird analyst David Leiker maintains an Outperform rating on Lear Group (NYSE:<a href='https://seekingalpha.com/symbol/LEA' title='Lear Corporation'>LEA</a>) and increases the price target from $140 to $158.</li><li>Leiker says the <a href=\"https://seekingalpha.com/news/3425948-lear-beats-0_12-misses-revenue\" target=\"_blank\">earnings report </a>shows that the \"worst of the negative earnings revisions appear to be behind\" the company.</li><li>The analyst says the long-term revenue and cash flow stories remain attractive at current levels especially compared to peers.</li><li>Source: Bloomberg First Word.</li><li>Lear Corporation shares are <font color=\"green\">up 6.9%</font> to $159.30.</li></ul><div class=\"tiny-share-widget\" data-id=\"3426173\" data-linked=\"Baird ups Lear target after EPS beat\" data-tweet=\"$LEA - Baird ups Lear target after EPS beat https://seekingalpha.com/news/3426173-baird-ups-lear-target-after-eps-beat?source=tweet\" data-url=\"https://seekingalpha.com/news/3426173-baird-ups-lear-target-after-eps-beat\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:48 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3426168\" data-ts=\"1548448188\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GE\" target=\"_blank\">GE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3426168-ges-reworked-rail-deal-shows-company-desperate-for-cash-analyst-says\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">GE&#39;s reworked rail deal shows company &#39;desperate for cash,&#39; analyst says</a></h4><ul><li>General Electric (<a href='https://seekingalpha.com/symbol/GE' title='General Electric'>GE</a> <font color=\"green\">+4.4%</font>) surges to its highest level in nearly three months after <a href=\"https://seekingalpha.com/news/3426062-ge-wabtec-deal-revised-give-wabtec-shareholders-majority-holding\" target=\"_blank\">reworking the planned spinoff</a> of its transportation unit to provide more up-front cash, helping the company shore up its ailing balance sheet.</li><li>The revised deal gives a majority stake to Wabtec (<a href='https://seekingalpha.com/symbol/WBA' title='Walgreens Boots Alliance, Inc.'>WBA</a> <font color=\"green\">+0.8%</font>) shareholders, meaning it is now <a href=\"https://finance.yahoo.com/news/just-ugly-ge-apos-balance-162009357.html\" target=\"_blank\">taxable as a dividend for GE and its investors</a>; the move suggests investors could see a similar revision to GE's health care business divestiture, with GE possibly scrapping the spinoff altogether, writes Bloomberg's Brooke Sutherland.</li><li>The modified deal does  not appear to be beneficial to GE shareholders, says Gordon Haskett analyst John Inch, and GE's stated reason for its move is to strengthen the company's balance sheet, which reinforces Inch's view that GE is \"<a href=\"https://thefly.com/thestreet/realmoney/index.php/GE%3bWABid2853963/GE%3bWAB-GE-modification-of-Wabtec-deal-reflects-need-for-cash-says-Gordon-Haskett\" target=\"_blank\">desperate for cash</a> to pay down its debt and other liabilities as quickly as possible.\"</li></ul><div class=\"tiny-share-widget\" data-id=\"3426168\" data-linked=\"GE&#39;s reworked rail deal shows company &#39;desperate for cash,&#39; analyst says\" data-tweet=\"$GE $GE $WBA - GE&#39;s reworked rail deal shows company &#39;desperate for cash,&#39; analyst says https://seekingalpha.com/news/3426168-ges-reworked-rail-deal-shows-company-desperate-for-cash-analyst-says?source=tweet\" data-url=\"https://seekingalpha.com/news/3426168-ges-reworked-rail-deal-shows-company-desperate-for-cash-analyst-says\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:29 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>94&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3426167\" data-ts=\"1548446890\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DGLY\" target=\"_blank\">DGLY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3426167-technology-top-5-gainers-losers-of-3_05-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Technology - Top 5 Gainers / Losers as of 3.05 PM</a></h4><ul><li><strong>Gainers: </strong>Digital Ally(NASDAQ:<a href='https://seekingalpha.com/symbol/DGLY' title='Digital Ally, Inc.'>DGLY</a>) <font color=\"green\">+20%</font>. TSR (NASDAQ:<a href='https://seekingalpha.com/symbol/TSRI' title='TSR, Inc.'>TSRI</a>) <font color=\"green\">+18%</font>. Resonant (NASDAQ:<a href='https://seekingalpha.com/symbol/RESN' title='Resonant'>RESN</a>) <font color=\"green\">+15%</font>.Lantronix(NASDAQ:<a href='https://seekingalpha.com/symbol/LTRX' title='Lantronix, Inc.'>LTRX</a>) <font color=\"green\">+14%</font>. JinkoSolar Holding (NYSE:<a href='https://seekingalpha.com/symbol/JKS' title='JinkoSolar Holding Co., Ltd.'>JKS</a>) <font color=\"green\">+12%</font>.</li> <li><strong>Losers: </strong>China TechFaith Wireless Communication Technology Limited (NASDAQ:<a href='https://seekingalpha.com/symbol/CNTF' title='China TechFaith Wireless Communication Technology Limited'>CNTF</a>) <font color=\"red\">-13%</font>. Windstream Holdings(NASDAQ:<a href='https://seekingalpha.com/symbol/WIN' title='Windstream Holdings, Inc.'>WIN</a>) <font color=\"red\">-7%</font>. Intel Corporation (NASDAQ:<a href='https://seekingalpha.com/symbol/INTC' title='Intel Corporation'>INTC</a>) <font color=\"red\">-6%</font>. Frontier Communications Corporation (NYSE:<a href='https://seekingalpha.com/symbol/FTR' title='Frontier Communications Corporation'>FTR</a>) <font color=\"red\">-5%</font>. GDS Holdings Limited (NASDAQ:<a href='https://seekingalpha.com/symbol/GDS' title='GDS Holdings'>GDS</a>) <font color=\"red\">-5%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3426167\" data-linked=\"Technology - Top 5 Gainers / Losers as of 3.05 PM\" data-tweet=\"$DGLY $DGLY $TSRI - Technology - Top 5 Gainers / Losers as of 3.05 PM https://seekingalpha.com/news/3426167-technology-top-5-gainers-losers-of-3_05-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3426167-technology-top-5-gainers-losers-of-3_05-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:08 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3426166\" data-ts=\"1548446886\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CVS\" target=\"_blank\">CVS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3426166-amgens-aimovig-reportedly-excluded-from-cvs-plans\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Amgen&#39;s Aimovig reportedly excluded from CVS plans</a></h4><ul><li><a href=\"https://twitter.com/Subrat_Patnaik/status/1088881676942540800\" target=\"_blank\">According to Reuters</a>, CVS (NYSE:<a href='https://seekingalpha.com/symbol/CVS' title='CVS Health Corporation'>CVS</a>) has put new migraine drugs from Teva (NYSE:<a href='https://seekingalpha.com/symbol/TEVA' title='Teva Pharmaceutical Industries Limited'>TEVA</a>) and Eli Lilly (NYSE:<a href='https://seekingalpha.com/symbol/LLY' title='Eli Lilly and Company'>LLY</a>) on its list of covered medicines, while excluding Amgen's (NASDAQ:<a href='https://seekingalpha.com/symbol/AMGN' title='Amgen Inc.'>AMGN</a>) Aimovig.</li><li>Amgen dropped more than 2% when the news hit a few minutes back, but is now <font color=\"red\">down just 1.35%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3426166\" data-linked=\"Amgen&#39;s Aimovig reportedly excluded from CVS plans\" data-tweet=\"$CVS $CVS $TEVA - Amgen&#39;s Aimovig reportedly excluded from CVS plans https://seekingalpha.com/news/3426166-amgens-aimovig-reportedly-excluded-from-cvs-plans?source=tweet\" data-url=\"https://seekingalpha.com/news/3426166-amgens-aimovig-reportedly-excluded-from-cvs-plans\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:08 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3426164\" data-ts=\"1548446766\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WDC\" target=\"_blank\">WDC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3426164-semis-strong-on-western-digital-optimism\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Semis strong on Western Digital optimism</a></h4><ul><li>Semi stocks head towards the end of the week in the green after Western Digital's (<a href='https://seekingalpha.com/symbol/WDC' title='Western Digital Corporation'>WDC</a> <font color=\"green\">+7.2%</font>) <a href=\"https://seekingalpha.com/news/3425947-western-digital-plus-8-percent-guidance-update\" target=\"_blank\">guidance</a> created optimism about 2H demand improvements.</li><li>The Philadelphia Semiconductor Index is<font color=\"green\"> up 2.3%</font> compared to the <font color=\"green\">1.4%</font> gain for the tech sector (NYSEARCA:<a href='https://seekingalpha.com/symbol/XLK' title='Technology Select Sector SPDR ETF'>XLK</a>).</li><li>On the move:  Maxim Integrated (<a href='https://seekingalpha.com/symbol/MXIM' title='Maxim Integrated Products, Inc.'>MXIM</a> <font color=\"green\">+3.4%</font>), AMD (<a href='https://seekingalpha.com/symbol/AMD' title='Advanced Micro Devices, Inc.'>AMD</a> <font color=\"green\">+5.4%</font>), Teradyne (<a href='https://seekingalpha.com/symbol/TER' title='Teradyne Inc.'>TER</a> <font color=\"green\">+2.1%</font>), Lam Research (<a href='https://seekingalpha.com/symbol/LRCX' title='Lam Research Corporation'>LRCX</a> <font color=\"green\">+2.7%</font>), STMicroelectronics (<a href='https://seekingalpha.com/symbol/STM' title='STMicroelectronics NV'>STM</a> <font color=\"green\">+5.5%</font>), ON Semiconductors (<a href='https://seekingalpha.com/symbol/ON' title='ON Semiconductor Corporation'>ON</a> <font color=\"green\">+5.5%</font>), Xilinx (<a href='https://seekingalpha.com/symbol/XLNX' title='Xilinx, Inc.'>XLNX</a> <font color=\"green\">+4.1%</font>), ASML (<a href='https://seekingalpha.com/symbol/ASML' title='ASML Holding N.V.'>ASML</a> <font color=\"green\">+4.6%</font>), Micron (<a href='https://seekingalpha.com/symbol/MU' title='Micron Technology Inc.'>MU</a> <font color=\"green\">+6.9%</font>), Analog Devices (<a href='https://seekingalpha.com/symbol/ADI' title='Analog Devices Inc.'>ADI</a> <font color=\"green\">+2.7%</font>), Cirrus Logic (<a href='https://seekingalpha.com/symbol/CRUS' title='Cirrus Logic, Inc.'>CRUS</a> <font color=\"green\">+4.9%</font>), Seagate Technology (<a href='https://seekingalpha.com/symbol/STX' title='Seagate Technology'>STX</a> <font color=\"green\">+6.1%</font>), Marvell (<a href='https://seekingalpha.com/symbol/MRVL' title='Marvell Technology Group, Ltd.'>MRVL</a> <font color=\"green\">+5.9%</font>).</li><li>Exception: Intel (<a href='https://seekingalpha.com/symbol/INTC' title='Intel Corporation'>INTC</a> <font color=\"red\">-6%</font>) is still down on its <a href=\"https://seekingalpha.com/news/3425818-intel-minus-7-percent-downside-fy-revenue-guide\" target=\"_blank\">earnings misses</a> and downside FY revenue guidance.</li><li>Related semiconductor ETFs: <a href='https://seekingalpha.com/symbol/SOXL' title='Direxion Daily Semiconductor 3x Bull Shares ETF'>SOXL</a>, <a href='https://seekingalpha.com/symbol/SOXX' title='iShares PHLX SOX Semiconductor Sector Index ETF'>SOXX</a>, <a href='https://seekingalpha.com/symbol/SMH' title='VanEck Vectors Semiconductor ETF'>SMH</a>, <a href='https://seekingalpha.com/symbol/USD' title='ProShares Ultra Semiconductors ETF'>USD</a>, <a href='https://seekingalpha.com/symbol/PSI' title='Invesco Dynamic Semiconductors Portfolio ETF'>PSI</a>, <a href='https://seekingalpha.com/symbol/XSD' title='SPDR S&P Semiconductor ETF'>XSD</a>, <a href='https://seekingalpha.com/symbol/SOXS' title='Direxion Daily Semiconductor 3x Bear Shares ETF'>SOXS</a>, <a href='https://seekingalpha.com/symbol/SSG' title='ProShares UltraShort Semiconductors ETF'>SSG</a>, <a href='https://seekingalpha.com/symbol/FTXL' title='First Trust Nasdaq Semiconductor ETF'>FTXL</a>, <a href='https://seekingalpha.com/symbol/XTH' title='SPDR S&P Technology Hardware ETF'>XTH</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3426164\" data-linked=\"Semis strong on Western Digital optimism\" data-tweet=\"$WDC $WDC $XLK - Semis strong on Western Digital optimism https://seekingalpha.com/news/3426164-semis-strong-on-western-digital-optimism?source=tweet\" data-url=\"https://seekingalpha.com/news/3426164-semis-strong-on-western-digital-optimism\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:06 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>23&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3426163\" data-ts=\"1548445353\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VALE\" target=\"_blank\">VALE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3426163-vales-latest-dam-burst-to-bring-enhanced-oversight-and-fines-analyst-says\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Vale&#39;s latest dam burst to bring enhanced oversight and fines, analyst says</a></h4><ul><li>Vale (<a href='https://seekingalpha.com/symbol/VALE' title='Vale S.A.'>VALE</a> <font color=\"red\">-9.1%</font>) tumbles as much as 25% following the <a href=\"https://seekingalpha.com/news/3426114-vale-dam-breaks-brazils-minas-gerais-state\" target=\"_blank\">collapse of a mining dam</a> in southeastern Brazil, flooding a nearby community and raising fears of widespread contamination.</li><li>A local fire brigade reportedly is <a href=\"https://www.cnbc.com/2019/01/25/reuters-america-update-4-hundreds-missing-in-brazil-after-vale-tailings-dam-breaks-area-evacuated.html\" target=\"_blank\">searching for ~200 people still unaccounted for</a> due to the incident.</li><li>J.P. Morgan analyst Rodolfo Angele says the dam burst likely will result in <a href=\"https://thefly.com/thestreet/realmoney/index.php/VALEid2854018/VALE-Vale-dam-breach-likely-to-bring-oversight-fines-says-JPMorgan\" target=\"_blank\">higher compliance</a> from authorities as well as financial fines, and generate enhanced scrutiny over the regulatory framework of the mining industry, especially over the usage of dams.</li><li>Angele notes Vale produces ~60% of its iron ore through operations that rely on dams.</li></ul><div class=\"tiny-share-widget\" data-id=\"3426163\" data-linked=\"Vale&#39;s latest dam burst to bring enhanced oversight and fines, analyst says\" data-tweet=\"$VALE - Vale&#39;s latest dam burst to bring enhanced oversight and fines, analyst says https://seekingalpha.com/news/3426163-vales-latest-dam-burst-to-bring-enhanced-oversight-and-fines-analyst-says?source=tweet\" data-url=\"https://seekingalpha.com/news/3426163-vales-latest-dam-burst-to-bring-enhanced-oversight-and-fines-analyst-says\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:42 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>26&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3426161\" data-ts=\"1548444584\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MDR\" target=\"_blank\">MDR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3426161-mcdermott-wins-contract-to-build-ethylene-furnaces-in-indonesia\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">McDermott wins contract to build ethylene furnaces in Indonesia</a></h4><ul><li>McDermott (<a href='https://seekingalpha.com/symbol/MDR' title='McDermott International, Inc.'>MDR</a> <font color='green'>+1.6%</font>) says it was <a href=\"https://seekingalpha.com/pr/17389954-mcdermott-announces-ethylene-furnace-award-indonesia\" target=\"_blank\">awarded a sizeable technology contract</a> to build ethylene cracking heaters in Indonesia; MDR defines a sizeable contract as between $1M-$50M.</li><li>\"Once complete, this complex will be one of the largest in Indonesia,  helping to satisfy the country's growing demand for petrochemical  products,\" MDR says.</li><li>The award follows the company's announcement last April for a contract for the license and basic engineering of the ethylene plant at  the Indonesian facility.</li></ul><div class=\"tiny-share-widget\" data-id=\"3426161\" data-linked=\"McDermott wins contract to build ethylene furnaces in Indonesia\" data-tweet=\"$MDR - McDermott wins contract to build ethylene furnaces in Indonesia https://seekingalpha.com/news/3426161-mcdermott-wins-contract-to-build-ethylene-furnaces-in-indonesia?source=tweet\" data-url=\"https://seekingalpha.com/news/3426161-mcdermott-wins-contract-to-build-ethylene-furnaces-in-indonesia\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:29 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3426159\" data-ts=\"1548443830\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/X\" target=\"_blank\">X</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3426159-u-s-steel-s-clairton-fire-big-issue-for-investors-analyst-says\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">U.S. Steel\u2019s Clairton fire a \u2018big issue&#39; for investors, analyst says</a></h4><ul><li>Analysts and investors are becoming more concerned about costs and  possible environmental repercussions from last month's fire at U.S.  Steel\u2019s (<a href='https://seekingalpha.com/symbol/X' title='United States Steel Corporation'>X</a> <font color=\"green\">+3.9%</font>) Clairton coke plant near Pittsburgh, says Keybanc analyst Phil Gibbs.</li><li>\u201cIt\u2019s a big issue, because they\u2019ve incited the passion of the local  community given near-term environmental or air-quality fallout,\u201d and  there is still little clarity on costs to repair the assets, according to Gibbs.</li><li>U.S. Steel has said that the Dec. 24 fire caused \u201csignificant damage to equipment and buildings, including units  necessary for the safe and effective operation of the desulfurization  process for coke oven gases.\u201d</li><li>Gibbs says the incident will cause some near-term operational inefficiency within the company's supply chain, and that investors will look for more information on impacts during the company\u2019s Jan. 31 earnings call.</li><li>Source: Bloomberg First Word</li></ul><div class=\"tiny-share-widget\" data-id=\"3426159\" data-linked=\"U.S. Steel\u2019s Clairton fire a \u2018big issue&#39; for investors, analyst says\" data-tweet=\"$X - U.S. Steel\u2019s Clairton fire a \u2018big issue&#39; for investors, analyst says https://seekingalpha.com/news/3426159-u-s-steel-s-clairton-fire-big-issue-for-investors-analyst-says?source=tweet\" data-url=\"https://seekingalpha.com/news/3426159-u-s-steel-s-clairton-fire-big-issue-for-investors-analyst-says\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:17 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3426153\" data-ts=\"1548442383\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BRS\" target=\"_blank\">BRS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3426153-bristow-group-leads-energy-materials-gainers-recon-technology-and-vale-only-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bristow Group leads Energy/Materials gainers; Recon Technology and Vale the only losers</a></h4><ul><li><b>Gainers:</b> Bristow Group (NYSE:<a href='https://seekingalpha.com/symbol/BRS' title='Bristow Group Inc.'>BRS</a>) <font color=\"green\">+21%</font>. Ferroglobe (NASDAQ:<a href='https://seekingalpha.com/symbol/GSM' title='Ferroglobe PLC'>GSM</a>) <font color=\"green\">+11%</font>. TETRA Technologies (NYSE:<a href='https://seekingalpha.com/symbol/TTI' title='Tetra Technologies Inc.'>TTI</a>) <font color=\"green\">+10%</font>. Gulf Resources (NASDAQ:<a href='https://seekingalpha.com/symbol/GURE' title='GULF RESOURCES INC'>GURE</a>) <font color=\"green\">+9%</font>. New Gold (NYSEMKT:<a href='https://seekingalpha.com/symbol/NGD' title='New Gold Inc'>NGD</a>) <font color=\"green\">+9%</font>.</li><li><b>Losers:</b> Recon Technology (NASDAQ:<a href='https://seekingalpha.com/symbol/RCON' title='Recon Technology, Ltd.'>RCON</a>) <font color=\"red\">-12%</font>. Vale S.A. (NYSE:<a href='https://seekingalpha.com/symbol/VALE' title='Vale S.A.'>VALE</a>) <font color=\"red\">-8%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3426153\" data-linked=\"Bristow Group leads Energy/Materials gainers; Recon Technology and Vale the only losers\" data-tweet=\"$BRS $BRS $GSM - Bristow Group leads Energy/Materials gainers; Recon Technology and Vale the only losers https://seekingalpha.com/news/3426153-bristow-group-leads-energy-materials-gainers-recon-technology-and-vale-only-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3426153-bristow-group-leads-energy-materials-gainers-recon-technology-and-vale-only-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:53 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3426151\" data-ts=\"1548441875\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MGNX\" target=\"_blank\">MGNX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3426151-macrogenics-on-go-to-resume-recruitment-in-mgd009-study-shares-up-3\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">MacroGenics on go to resume recruitment in MGD009 study; shares up 3%</a></h4><ul><li>MacroGenics (<a href='https://seekingalpha.com/symbol/MGNX' title='MacroGenics, Inc.'>MGNX</a> <font color=\"green\">+2.7%</font>) is up on almost triple normal volume on the heels of the FDA's <a href=\"https://seekingalpha.com/pr/17391975-macrogenics-announces-removal-partial-clinical-hold-mgd009-program-fda\" target=\"_blank\">removal </a>of the partial clinical hold on its Phase 1 clinical trial for bispecific DART molecule MGD009.</li><li>The partial clinical hold, which suspends new patient recruitment while allowing currently enrolled participants to continue treatment, was instituted after the company reported liver-related adverse events. The company says it resolved the issue without a significant delay in the program.</li></ul><div class=\"tiny-share-widget\" data-id=\"3426151\" data-linked=\"MacroGenics on go to resume recruitment in MGD009 study; shares up 3%\" data-tweet=\"$MGNX - MacroGenics on go to resume recruitment in MGD009 study; shares up 3% https://seekingalpha.com/news/3426151-macrogenics-on-go-to-resume-recruitment-in-mgd009-study-shares-up-3?source=tweet\" data-url=\"https://seekingalpha.com/news/3426151-macrogenics-on-go-to-resume-recruitment-in-mgd009-study-shares-up-3\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:44 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3426147\" data-ts=\"1548441168\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ORGO\" target=\"_blank\">ORGO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3426147-wild-ride-organogenesis\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">The wild ride with Organogenesis</a></h4><ul><li>Ultra-thinly traded Organogenesis (<a href='https://seekingalpha.com/symbol/ORGO' title='Organogenesis Holdings Inc'>ORGO</a> <font color=\"green\">+6.8%</font>) is a shining example of the wild ride only a biotech can deliver. On October 30, 2018, Nasdaq suspended trading in the regenerative medicine firm's shares ahead of delisting due to its failure to meet its requirement of at least 400 round lot investors. The company <a href=\"https://www.sec.gov/Archives/edgar/data/1661181/000119312519003890/d687304d8k.htm\" target=\"_blank\">attended a hearing</a> on December 13 to present its plan to address the issue. Nasdaq granted its request for continued listing of its Class A common stock until March 31 of this year while it implements its plan to increase the number of round lot holders. The trading halt was lifted at the open on January 8. Only 2,000 shares were traded at a range of $13.00 - 13.45.</li><li>The next day, January 9, shares rocketed to an intraday high of $310.90 before retracing to close at $82.35, all on turnover of only 28,200. The day after, shares peaked at $241.47 before settling at $148.85, on turnover of only 4,300. The stock is currently exchanging hands <font color=\"red\">88%</font> below that price.</li><li>Shares are up a more pedestrian amount today on turnover of ~178K shares.</li></ul><div class=\"tiny-share-widget\" data-id=\"3426147\" data-linked=\"The wild ride with Organogenesis\" data-tweet=\"$ORGO - The wild ride with Organogenesis https://seekingalpha.com/news/3426147-wild-ride-organogenesis?source=tweet\" data-url=\"https://seekingalpha.com/news/3426147-wild-ride-organogenesis\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:32 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3426225\" data-ts=\"1548439728\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NEP\" target=\"_blank\">NEP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3426225-nextera-energy-partnersminus-6-after-disappointing-q4-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">NextEra Energy Partners -6% after disappointing Q4 results</a></h4><ul><li>NextEra Energy Partners (<a href='https://seekingalpha.com/symbol/NEP' title='NextEra Energy Partners, LP'>NEP</a> <font color='red'>-6.3%</font>) tumbles to its lowest price of the new year after posting an unexpected <a href=\"https://seekingalpha.com/news/3425995-nextera-energy-partners-misses-0_81-misses-revenue\" target=\"_blank\">Q4 loss</a>, a 21% Y/Y revenue decline to $155M and Q4 adjusted EBITDA of $165M vs. $200M in the year-ago quarter.</li><li>NEP says it continues to expect 12%-15%/year growth in limited partner distributions as a reasonable range of expectations through at least 2023, and foresees the annualized rate of its Q4 2019 distribution, payable in February 2020, in a range of $2.08-$2.14/unit.</li><li>Absent any impact from a potential PG&amp;E bankruptcy filing, NEP says its portfolio ended the year with adjusted EBITDA and CAFD run rates in line with its expectations.</li><li>For the full year, NEP says it had \"a terrific year of execution, delivering on its growth objectives for adjusted EBITDA, CAFD and limited partner unitholder distributions, while outperforming both the S&amp;P and other yieldcos by 7% on average.\"</li></ul><div class=\"tiny-share-widget\" data-id=\"3426225\" data-linked=\"NextEra Energy Partners -6% after disappointing Q4 results\" data-tweet=\"$NEP - NextEra Energy Partners -6% after disappointing Q4 results https://seekingalpha.com/news/3426225-nextera-energy-partnersminus-6-after-disappointing-q4-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3426225-nextera-energy-partnersminus-6-after-disappointing-q4-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:08 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3426141\" data-ts=\"1548439172\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RAND\" target=\"_blank\">RAND</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3426141-rand-capital-leads-financial-gainers-360-finance-and-hilltop-holdings-among-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Rand Capital leads financial gainers; 360 Finance and Hilltop Holdings among losers</a></h4><ul><li><b>Gainers:</b> Rand Capital (NASDAQ:<a href='https://seekingalpha.com/symbol/RAND' title='Rand Capital'>RAND</a>) <font color=\"green\">+30%</font>. Parke Bancorp (NASDAQ:<a href='https://seekingalpha.com/symbol/PKBK' title='Parke Bancorp, Inc.'>PKBK</a>) <font color=\"green\">+11%</font>. PPDAI Group (NYSE:<a href='https://seekingalpha.com/symbol/PPDF' title='PPDAI Group Inc.'>PPDF</a>) <font color=\"green\">+9%</font>. Mmtec (<a href='https://seekingalpha.com/symbol/MTC' title='MMTEC Inc'>MTC</a>) <font color=\"green\">+6%</font>. Dime Community Bancshares (NASDAQ:<a href='https://seekingalpha.com/symbol/DCOM' title='Dime Community Bancshares, Inc.'>DCOM</a>) <font color=\"green\">+6%</font>.</li><li><b>Losers:</b> China Lending (NASDAQ:<a href='https://seekingalpha.com/symbol/CLDC' title='China Lending Corporation'>CLDC</a>) <font color=\"red\">-13%</font>. 360 Finance (NASDAQ:<a href='https://seekingalpha.com/symbol/QFIN' title='360 Finance'>QFIN</a>) <font color=\"red\">-6%</font>. Hilltop Holdings (NYSE:<a href='https://seekingalpha.com/symbol/HTH' title='Hilltop Holdings Inc.'>HTH</a>) <font color=\"red\">-6%</font>. Puhui Wealth Investment Management (<a href='https://seekingalpha.com/symbol/PHCF' title='Puhui Wealth Investment Management Co Ltd'>PHCF</a>) <font color=\"red\">-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3426141\" data-linked=\"Rand Capital leads financial gainers; 360 Finance and Hilltop Holdings among losers\" data-tweet=\"$RAND $RAND $PKBK - Rand Capital leads financial gainers; 360 Finance and Hilltop Holdings among losers https://seekingalpha.com/news/3426141-rand-capital-leads-financial-gainers-360-finance-and-hilltop-holdings-among-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3426141-rand-capital-leads-financial-gainers-360-finance-and-hilltop-holdings-among-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:59 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3426144\" data-ts=\"1548439030\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JKS\" target=\"_blank\">JKS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3426144-jinkosolarplus-28-over-three-days-following-announcements\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">JinkoSolar +28% over three days following announcements</a></h4><ul><li>JinkoSolar (<a href='https://seekingalpha.com/symbol/JKS' title='JinkoSolar Holding Co., Ltd.'>JKS</a> <font color='green'>+15.2%</font>) shares have surged nearly 30% over the last three sessions, reaching levels last held in August, following two company announcements.</li><li>JKS said today that a <a href=\"https://seekingalpha.com/pr/17391470-jinkosolar-large-area-n-type-topcon-monocrystalline-silicon-solar-cell-reaches-record-high\" target=\"_blank\">record high efficiency</a> of 24.2% was achieved by its large-area N-type TOPCon monocrystalline silicon solar cell, which features the company's HOT cell design, in testing at the Chinese Academy of Sciences.</li><li><a href=\"https://seekingalpha.com/pr/17386345-jinkosolar-supplies-5-mw-mesokomo-project-greece\" target=\"_blank\">Earlier this week</a>, JKS said its affiliate had supplied 5 MW of PV solar  modules to Juwi Hellas for use in the Mesokomo Project in Greece.</li></ul><div class=\"tiny-share-widget\" data-id=\"3426144\" data-linked=\"JinkoSolar +28% over three days following announcements\" data-tweet=\"$JKS - JinkoSolar +28% over three days following announcements https://seekingalpha.com/news/3426144-jinkosolarplus-28-over-three-days-following-announcements?source=tweet\" data-url=\"https://seekingalpha.com/news/3426144-jinkosolarplus-28-over-three-days-following-announcements\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:57 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3426135\" data-ts=\"1548438032\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ORGO\" target=\"_blank\">ORGO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3426135-orgo-rmd-and-pcg-among-midday-movers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ORGO, RMD and PCG among midday movers</a></h4><ul><li><strong>Gainers:</strong> Organogenesis Holdings (<a href='https://seekingalpha.com/symbol/ORGO' title='Organogenesis Holdings Inc'>ORGO</a>) <font color=\"green\">+57%</font>. Rand Capital (NASDAQ:<a href='https://seekingalpha.com/symbol/RAND' title='Rand Capital'>RAND</a>) <font color=\"green\">+32%</font>. PHI (NASDAQ:<a href='https://seekingalpha.com/symbol/PHII' title='PHI, Inc.'>PHII</a>) <font color=\"green\">+26%</font>. ClearOne (NASDAQ:<a href='https://seekingalpha.com/symbol/CLRO' title='ClearOne, Inc.'>CLRO</a>) <font color=\"green\">+23%</font>. Bristow Group (NYSE:<a href='https://seekingalpha.com/symbol/BRS' title='Bristow Group Inc.'>BRS</a>) <font color=\"green\">+20%</font>. Digital Ally (NASDAQ:<a href='https://seekingalpha.com/symbol/DGLY' title='Digital Ally, Inc.'>DGLY</a>) <font color=\"green\">+17%</font>. SITO Mobile (NASDAQ:<a href='https://seekingalpha.com/symbol/SITO' title='SITO Mobile, Ltd.'>SITO</a>) <font color=\"green\">+16%</font>. Achaogen (NASDAQ:<a href='https://seekingalpha.com/symbol/AKAO' title='Achaogen'>AKAO</a>) <font color=\"green\">+16%</font>. Check-Cap (NASDAQ:<a href='https://seekingalpha.com/symbol/CHEK' title='Check-Cap Ltd.'>CHEK</a>) <font color=\"green\">+14%</font>.</li> <li><strong>Losers:</strong> ResMed (NYSE:<a href='https://seekingalpha.com/symbol/RMD' title='ResMed Inc.'>RMD</a>) <font color=\"red\">-18%</font>. ToughBuilt Industries (NASDAQ:<a href='https://seekingalpha.com/symbol/TBLT' title='ToughBuilt Industries, Inc.'>TBLT</a>) <font color=\"red\">-16%</font>. Titan Medical (NASDAQ:<a href='https://seekingalpha.com/symbol/TMDI' title='Titan Medical Inc.'>TMDI</a>) <font color=\"red\">-13%</font>. PG&amp;E Corporation (NYSE:<a href='https://seekingalpha.com/symbol/PCG' title='PG&E Corporation'>PCG</a>) <font color=\"red\">-13%</font>. China Lending Corporation (NASDAQ:<a href='https://seekingalpha.com/symbol/CLDC' title='China Lending Corporation'>CLDC</a>) <font color=\"red\">-13%</font>. Recon Technology (NASDAQ:<a href='https://seekingalpha.com/symbol/RCON' title='Recon Technology, Ltd.'>RCON</a>) <font color=\"red\">-12%</font>. Interlink Electronics (NASDAQ:<a href='https://seekingalpha.com/symbol/LINK' title='Interlink Electronics'>LINK</a>) <font color=\"red\">-11%</font>. Dean Foods (NYSE:<a href='https://seekingalpha.com/symbol/DF' title='Dean Foods Company'>DF</a>) <font color=\"red\">-9%</font>. ASLAN Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/ASLN' title='ASLAN Pharmaceuticals'>ASLN</a>) <font color=\"red\">-9%</font>. Miragen Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/MGEN' title='Miragen Therapeutics, Inc.'>MGEN</a>) <font color=\"red\">-8%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3426135\" data-linked=\"ORGO, RMD and PCG among midday movers\" data-tweet=\"$ORGO $ORGO $RAND - ORGO, RMD and PCG among midday movers https://seekingalpha.com/news/3426135-orgo-rmd-and-pcg-among-midday-movers?source=tweet\" data-url=\"https://seekingalpha.com/news/3426135-orgo-rmd-and-pcg-among-midday-movers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:40 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3426125\" data-ts=\"1548436862\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SIEGY\" target=\"_blank\">SIEGY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3426125-siemens-alstom-offer-new-concessions-to-save-rail-deal-bloomberg\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Siemens, Alstom offer new concessions to save rail deal - Bloomberg</a></h4><ul><li>Siemens (<a href='https://seekingalpha.com/symbol/SIEGY' title='Siemens AG ADR'>OTCPK:SIEGY</a> <font color='green'>+1.9%</font>) and Alstom (<a href='https://seekingalpha.com/symbol/ALSMY' title='Alstom ADR'>OTCPK:ALSMY</a> <font color='green'>+2.8%</font>) have <a href=\"https://finance.yahoo.com/news/siemens-alstom-offer-remedies-save-161304698.html\" target=\"_blank\">offered a fresh package of concessions</a> designed to ease European Union antitrust concerns that their planned rail merger would hurt competition in the region, Bloomberg reports.</li><li>The companies have offered to sell signaling assets as well as longer licensing agreements, and have identified potential acquirers, according to the report.</li><li>Without the remedies, the deal reportedly was <a href=\"https://seekingalpha.com/news/3424380-siemens-alstom-rail-merger-set-rejected-eu-authorities-reuters\" target=\"_blank\">expected to be blocked</a> by the Europe\u2019s antitrust regulator.</li></ul><div class=\"tiny-share-widget\" data-id=\"3426125\" data-linked=\"Siemens, Alstom offer new concessions to save rail deal - Bloomberg\" data-tweet=\"$SIEGY $SIEGY $ALSMY - Siemens, Alstom offer new concessions to save rail deal - Bloomberg https://seekingalpha.com/news/3426125-siemens-alstom-offer-new-concessions-to-save-rail-deal-bloomberg?source=tweet\" data-url=\"https://seekingalpha.com/news/3426125-siemens-alstom-offer-new-concessions-to-save-rail-deal-bloomberg\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:21 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3426124\" data-ts=\"1548436793\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CORT\" target=\"_blank\">CORT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3426124-corcept-down-6-on-bearish-report\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Corcept down 6% on bearish report</a></h4><ul><li>Corcept Therapeutics (<a href='https://seekingalpha.com/symbol/CORT' title='Corcept Therapeutics Incorporated'>CORT</a> <font color=\"red\">-5.8%</font>) slumps on modestly higher volume in apparent reaction to a <a href=\"http://sirf-online.org/2019/01/25/corcept-therapeutics-the-company-that-perfectly-explains-the-health-care-crisis/\" target=\"_blank\">bearish report</a> from Southern Investigative Reporting Foundation &#40;SIRF&#41;. Shares have dropped over <font color=\"red\">13%</font> since Wednesday.</li><li>Author Roddy Boyd says the company's lone drug, <a href=\"https://www.korlym.com/hcp/safety/important-prescribing-considerations/\" target=\"_blank\">Korlym</a> (mifepristone), is merely a repurposed abortion pill (known as RU-486) that the company failed to market as a treatment for depression. He questions the robustness of the data supporting U.S. approval for a pituitary gland disorder called Cushing's syndrome, characterized by excess cortisol in the body, adding that the European Medicines Agency declined to approve it for this use due to, among other things, \"limited\" evidence of effectiveness despite an annual cost of more than $300K.</li><li>Yesterday morning, ValueEngine <a href=\"https://www.fairfieldcurrent.com/news/2019/01/25/corcept-therapeutics-cort-downgraded-by-valuengine-to-sell.html\" target=\"_blank\">cut its rating</a> to Sell. According to MarketBeat, <a href=\"https://www.marketbeat.com/stocks/NASDAQ/CORT/price-target/\" target=\"_blank\">five of six </a>sell-siders have Buy ratings with price targets of $20 - 32.</li><li>Consensus Q4 view is EPS of $0.17 on revenue of $70.4M.</li></ul><div class=\"tiny-share-widget\" data-id=\"3426124\" data-linked=\"Corcept down 6% on bearish report\" data-tweet=\"$CORT - Corcept down 6% on bearish report https://seekingalpha.com/news/3426124-corcept-down-6-on-bearish-report?source=tweet\" data-url=\"https://seekingalpha.com/news/3426124-corcept-down-6-on-bearish-report\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:19 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>18&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3426123\" data-ts=\"1548436431\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CHRS\" target=\"_blank\">CHRS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3426123-coherus-sues-amgen-over-humira-biosimilar\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Coherus sues Amgen over Humira biosimilar</a></h4><ul><li>Coherus BioSciences (<a href='https://seekingalpha.com/symbol/CHRS' title='Coherus BioSciences'>CHRS</a> <font color=\"green\">+4.7%</font>) has filed <a href=\"https://seekingalpha.com/pr/17391915-coherus-biosciences-announces-filing-patent-infringement-suit-amgen-directed-amgen-s-humira\" target=\"_blank\">litigation </a>against Amgen (<a href='https://seekingalpha.com/symbol/AMGN' title='Amgen Inc.'>AMGN</a> <font color=\"red\">-1.4%</font>) claiming its Humira biosimilar, Amgevita, infringes on three U.S. Coherus patents protecting its Humira biosimilar candidate CHS-1420, each covering stable formulations of adalimumab. Coherus plans to file a U.S. marketing application in Q4.</li></ul><div class=\"tiny-share-widget\" data-id=\"3426123\" data-linked=\"Coherus sues Amgen over Humira biosimilar\" data-tweet=\"$CHRS $CHRS $AMGN - Coherus sues Amgen over Humira biosimilar https://seekingalpha.com/news/3426123-coherus-sues-amgen-over-humira-biosimilar?source=tweet\" data-url=\"https://seekingalpha.com/news/3426123-coherus-sues-amgen-over-humira-biosimilar\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:13 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3426122\" data-ts=\"1548435901\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AAPL\" target=\"_blank\">AAPL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3426122-apple-planning-major-ipad-refresh\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Apple planning major iPad refresh?</a></h4><ul><li>Apple (<a href='https://seekingalpha.com/symbol/AAPL' title='Apple Inc.'>AAPL</a> <font color='green'>+2.8%</font>) has received Eurasian Economic Commission approvals for six new tablets, suggesting a major iPad refresh.</li><li>The registrations were first spotted by <a href=\"https://www.mysmartprice.com/gear/apple-new-ipads-eec/\" target=\"_blank\">MySmartPrice</a> and <a href=\"https://venturebeat.com/2019/01/25/apple-adds-6-new-ipads-to-regulatory-database-hinting-at-major-refresh/\" target=\"_blank\">VentureBeat</a> points out that \"the list appears to correspond with three clusters of Wi-Fi and Cellular models.\"</li><li>Last week, Digitimes <a href=\"https://seekingalpha.com/news/3423810-apple-launching-new-low-cost-ipads-report\" target=\"_blank\">sources </a>said Apple would launch two entry-level iPads in 1H19 likely updating the iPad mini 4 and last year's $329 iPad.</li></ul><div class=\"tiny-share-widget\" data-id=\"3426122\" data-linked=\"Apple planning major iPad refresh?\" data-tweet=\"$AAPL - Apple planning major iPad refresh? https://seekingalpha.com/news/3426122-apple-planning-major-ipad-refresh?source=tweet\" data-url=\"https://seekingalpha.com/news/3426122-apple-planning-major-ipad-refresh\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:05 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>113&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3426120\" data-ts=\"1548435705\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LFVN\" target=\"_blank\">LFVN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3426120-delphi-technologies-and-coty-among-consumer-gainers-dean-foods-and-orchids-paper-products-in\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Delphi Technologies and Coty among consumer gainers; Dean Foods and Orchids Paper Products in losers</a></h4><ul><li><b>Gainers: </b>LifeVantage (NASDAQ:<a href='https://seekingalpha.com/symbol/LFVN' title='LifeVantage Corporation'>LFVN</a>) <font color=\"green\">+8%</font>. Delphi Technologies (NYSE:<a href='https://seekingalpha.com/symbol/DLPH' title='Delphi Technologies PLC'>DLPH</a>) <font color=\"green\">+7%</font>. Coty (NYSE:<a href='https://seekingalpha.com/symbol/COTY' title='Coty Inc.'>COTY</a>) <font color=\"green\">+6%</font>. Funko (NASDAQ:<a href='https://seekingalpha.com/symbol/FNKO' title='Funko, Inc.'>FNKO</a>) <font color=\"green\">+5%</font>. Lear Corporation (NYSE:<a href='https://seekingalpha.com/symbol/LEA' title='Lear Corporation'>LEA</a>) <font color=\"green\">+5%</font>.</li><li><b>Losers: </b>Dean Foods (NYSE:<a href='https://seekingalpha.com/symbol/DF' title='Dean Foods Company'>DF</a>) <font color=\"red\">-9%</font>. Orchids Paper Products (NYSEMKT:<a href='https://seekingalpha.com/symbol/TIS' title='Orchids Paper Products Company'>TIS</a>) <font color=\"red\">-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3426120\" data-linked=\"Delphi Technologies and Coty among consumer gainers; Dean Foods and Orchids Paper Products in losers\" data-tweet=\"$LFVN $LFVN $DLPH - Delphi Technologies and Coty among consumer gainers; Dean Foods and Orchids Paper Products in losers https://seekingalpha.com/news/3426120-delphi-technologies-and-coty-among-consumer-gainers-dean-foods-and-orchids-paper-products-in?source=tweet\" data-url=\"https://seekingalpha.com/news/3426120-delphi-technologies-and-coty-among-consumer-gainers-dean-foods-and-orchids-paper-products-in\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:01 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3426114\" data-ts=\"1548434832\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VALE\" target=\"_blank\">VALE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3426114-vale-dam-breaks-in-brazils-minas-gerais-state\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Vale dam breaks in Brazil&#39;s Minas Gerais state</a></h4><ul><li>Vale (<a href='https://seekingalpha.com/symbol/VALE' title='Vale S.A.'>VALE</a> <font color=\"red\">-7.6%</font>) shares plunge following reports that one of its dams in Brazil's Minas Gerais state has <a href=\"https://www.reuters.com/article/us-brazil-vale-disaster/brazilian-miner-vales-dam-breaks-in-minas-gerais-state-report-idUSKCN1PJ1WT?il=0\" target=\"_blank\">ruptured</a>, pouring out mud into the surrounding area and prompting an evacuation of local residents.</li><li>Reuters reports the local fire department confirmed the dam break in Brumadinho near Belo Horizonte, and says there are unconfirmed reports of fatalities resulting from the incident.</li><li>The accident follows the 2015 deadly dam failure at Samarco, Vale's joint venture with BHP, that became Brazil's worst-ever environmental disaster.</li><li><strong>Update at 12:10 p.m.</strong>: Vale says early indications are that leaked tailings from the Corrego de Feijao mine had spread into its administrative area and to parts of the local community, but local authorities say they have no confirmed reports of fatalities.</li></ul><div class=\"tiny-share-widget\" data-id=\"3426114\" data-linked=\"Vale dam breaks in Brazil&#39;s Minas Gerais state\" data-tweet=\"$VALE - Vale dam breaks in Brazil&#39;s Minas Gerais state https://seekingalpha.com/news/3426114-vale-dam-breaks-in-brazils-minas-gerais-state?source=tweet\" data-url=\"https://seekingalpha.com/news/3426114-vale-dam-breaks-in-brazils-minas-gerais-state\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:47 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>22&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3426112\" data-ts=\"1548434207\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PCG\" target=\"_blank\">PCG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3426112-pg-and-e-bankruptcy-still-likely-despite-positive-fire-report-legal-experts-say\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">PG&amp;E bankruptcy still likely despite positive fire report, legal experts say</a></h4><ul><li>Legal experts say the conclusion by California fire investigators that PG&amp;E (<a href='https://seekingalpha.com/symbol/PCG' title='PG&E Corporation'>PCG</a> <font color=\"green\">+22.7%</font>) equipment <a href=\"https://seekingalpha.com/news/3425757-pg-and-e-plus-25-percent-investigation-reportedly-clears-company-2017-wildfires\" target=\"_blank\">did not ignite a 2017 wine country wildfire</a> probably would not stop the company from <a href=\"https://www.seattletimes.com/business/experts-pge-bankruptcy-likely-despite-positive-fire-report/\" target=\"_blank\">going ahead with its planned bankruptcy</a>.</li><li>Bankruptcy will give PG&amp;E \"breathing space\" to formulate a plan to prevent its equipment from causing more catastrophic fires in the future, says bankruptcy attorney Jared Ellias, but \"they are not out of the woods. There are more fires to come.\"</li><li>Avoiding jury trials makes it likely that PG&amp;E will still file for  bankruptcy, says Michael Kelly, an attorney representing victims of several fires in lawsuits against PG&amp;E; \"I don\u2019t think it has anything to do with money,\" Kelly says. \"I think it all has to do with lawsuit tactics.\"</li><li>J.P. Morgan analyst Christopher Turnure estimates PG&amp;E now is largely absolved of $7B of liabilities but continues to face ~$28B of gross fire liabilities, and potential liabilities continue to exceed the financing capacity of the company.</li></ul><div class=\"tiny-share-widget\" data-id=\"3426112\" data-linked=\"PG&amp;E bankruptcy still likely despite positive fire report, legal experts say\" data-tweet=\"$PCG - PG&amp;E bankruptcy still likely despite positive fire report, legal experts say https://seekingalpha.com/news/3426112-pg-and-e-bankruptcy-still-likely-despite-positive-fire-report-legal-experts-say?source=tweet\" data-url=\"https://seekingalpha.com/news/3426112-pg-and-e-bankruptcy-still-likely-despite-positive-fire-report-legal-experts-say\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:36 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>36&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3426110\" data-ts=\"1548433791\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MOG.A\" target=\"_blank\">MOG.A</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3426110-moogplus-5-on-q1-result-beats-reaffirms-fy19-outlook\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Moog +5% on Q1 result beats; reaffirms FY19 outlook</a></h4><ul><li>Moog (<a href='https://seekingalpha.com/symbol/MOG.A' title='Moog Inc.'>MOG.A</a> <font color=\"green\">+5%</font>) reported Q1 sales growth of 8.4% Y/Y to $680M, with Aircraft Controls sales of $304.05M (+9.2% Y/Y); Space and Defense Controls sales of $156.07M (+17% Y/Y); and Industrial Systems sales of $219.56M (+1.8% Y/Y).</li><li>Q1 Gross margin was flat at 29.4% and operating margin <font color=\"green\">improved by 93 bps</font> to 11.7%.</li><li>Segment operating margins: Aircraft Controls 10.9% <font color=\"red\">down 20 bps</font>; Space and Defense Controls 11.8% <font color=\"red\">down 50 bps</font>; and Industrial Systems 12.6% <font color=\"green\">up 340 bps</font>.</li><li>Q1 Expenses: R&amp;D $31.87M (-1.4% Y/Y) and SG&amp;A $96.33M (+1.8% Y/Y).</li><li>Net cash provided by operating activities was $64.24M, compared to $44.17M a year ago.</li><li>Total backlog was $2.1B, with consolidated 12-month backlog at $1.4B (+10% Y/Y).</li><li>Company has Cash, cash equivalents and restricted cash of $110.76M, as of December 29, 2018.</li><li><strong>FY19 Outlook, reaffirmed</strong>: Sales $2.88B; EPS $5.05-5.40; operating margin 11.7%; Cash flow from operations of $280M and tax rate 26%.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3426005-moog-beats-0_08-beats-revenue\" target=\"_blank\">Moog beats by $0.08, beats on revenue</a> (Jan. 25)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3426012-moog-declares-0_25-dividend\" target=\"_blank\">Moog declares $0.25 dividend</a> (Jan. 25)</li></ul><div class=\"tiny-share-widget\" data-id=\"3426110\" data-linked=\"Moog +5% on Q1 result beats; reaffirms FY19 outlook\" data-tweet=\"$MOG.A $MOG.B - Moog +5% on Q1 result beats; reaffirms FY19 outlook https://seekingalpha.com/news/3426110-moogplus-5-on-q1-result-beats-reaffirms-fy19-outlook?source=tweet\" data-url=\"https://seekingalpha.com/news/3426110-moogplus-5-on-q1-result-beats-reaffirms-fy19-outlook\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:29 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3426108\" data-ts=\"1548433648\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OSIS\" target=\"_blank\">OSIS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3426108-osi-systemsplus-11_9-post-q2-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">OSI Systems +11.9% post Q2 results</a></h4><ul><li>OSI Systems (<a href='https://seekingalpha.com/symbol/OSIS' title='OSI Systems, Inc.'>OSIS</a> <font color=\"green\">+11.9%</font>) reports <a href=\"https://seekingalpha.com/pr/17391125-osi-systems-reports-fiscal-2019-second-quarter-financial-results\" target=\"_blank\">Q2</a> revenue growth of 9.2% Y/Y to 303.2M.</li><li>The Company\u2019s book-to-bill ratio for equipment and related services was 0.9.</li><li>Security division delivered record Q2 revenues of $189M (+10% Y/Y).</li><li>The performance in Healthcare division improved significantly from the Q1, bookings accelerated leading to stronger sales.</li><li>Optoelectronics and Manufacturing division continued to perform well in the quarter delivering Y/Y sales growth of 13%, operating margin expansion, and strong cash flow.</li><li>The Company\u2019s backlog was ~$998M representing a 20% Y/Y increase.</li><li>Operating cash flow during the quarter ended December 31, 2018 was $43.7M, and capex were $4.8M.</li><li><b>Revised 2019 Outlook:</b> Sales to a range of $1.15-1.185B, which would represent growth of 6%-9% Y/Y, increased non-GAAP EPS to $3.93-4.10.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3425775-osi-systems-beats-0_23-beats-revenue\" target=\"_blank\">OSI Systems beats by $0.23, beats on revenue</a> (Jan. 24 2019)</li></ul><div class=\"tiny-share-widget\" data-id=\"3426108\" data-linked=\"OSI Systems +11.9% post Q2 results\" data-tweet=\"$OSIS - OSI Systems +11.9% post Q2 results https://seekingalpha.com/news/3426108-osi-systemsplus-11_9-post-q2-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3426108-osi-systemsplus-11_9-post-q2-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:27 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3426105\" data-ts=\"1548433090\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CHEK\" target=\"_blank\">CHEK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3426105-check-cap-up-12\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Check-Cap up 12%</a></h4><ul><li>Thinly traded nano cap Check-Cap (<a href='https://seekingalpha.com/symbol/CHEK' title='Check-Cap Ltd.'>CHEK</a> <font color=\"green\">+11.9%</font>) breaks out of brief consolidation on almost 60% higher volume. Shares have doubled since touching $1.62 on December 21, 2018.</li><li>No particular news accounts for the action. Final results from a post-CE Mark study on its C-Scan colorectal cancer screening capsule should be available next quarter. A U.S. pilot study should launch as well (<a href=\"https://www.sec.gov/Archives/edgar/data/1610590/000117891319000056/exhibit_99-1.htm\" target=\"_blank\">corporate presentation</a>, slide #20).</li><li>In July 2018, it filed a <a href=\"https://www.sec.gov/Archives/edgar/data/1610590/000117891318002115/zk1821909.htm\" target=\"_blank\">prospectus </a>for a $100M shelf offering of units, warrants and subscription rights. At the end of September 2018, it had $17.6M in quick assets while operations consumed $7.3M during the first three months of the year.</li></ul><div class=\"tiny-share-widget\" data-id=\"3426105\" data-linked=\"Check-Cap up 12%\" data-tweet=\"$CHEK - Check-Cap up 12% https://seekingalpha.com/news/3426105-check-cap-up-12?source=tweet\" data-url=\"https://seekingalpha.com/news/3426105-check-cap-up-12\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:18 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3426103\" data-ts=\"1548432452\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CHEK\" target=\"_blank\">CHEK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3426103-avid-bioservices-and-check-cap-among-healthcare-gainers-resmed-leads-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Avid Bioservices and Check-Cap among healthcare gainers; ResMed leads the losers</a></h4><ul><li><b>Gainers: </b>Check-Cap (NASDAQ:<a href='https://seekingalpha.com/symbol/CHEK' title='Check-Cap Ltd.'>CHEK</a>) <font color=\"green\">+12%</font>. Mersana Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/MRSN' title='Mersana Therapeutics'>MRSN</a>) <font color=\"green\">+10%</font>. CollPlant Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/CLGN' title='CollPlant'>CLGN</a>) <font color=\"green\">+10%</font>. Avid Bioservices (NASDAQ:<a href='https://seekingalpha.com/symbol/CDMO' title='Avid Bioservices, Inc.'>CDMO</a>) <font color=\"green\">+10%</font>. Arcus Biosciences (NYSE:<a href='https://seekingalpha.com/symbol/RCUS' title='Arcus Biosciences'>RCUS</a>) <font color=\"green\">+9%</font>.</li><li><b>Losers: </b>ResMed (NYSE:<a href='https://seekingalpha.com/symbol/RMD' title='ResMed Inc.'>RMD</a>) <font color=\"red\">-16%</font>. Titan Medical (NASDAQ:<a href='https://seekingalpha.com/symbol/TMDI' title='Titan Medical Inc.'>TMDI</a>) <font color=\"red\">-14%</font>. ASLAN Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/ASLN' title='ASLAN Pharmaceuticals'>ASLN</a>) <font color=\"red\">-10%</font>. Titan Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/TTNP' title='Titan Pharmaceuticals, Inc.'>TTNP</a>) <font color=\"red\">-7%</font>. OpGen (NASDAQ:<a href='https://seekingalpha.com/symbol/OPGN' title='OpGen'>OPGN</a>) <font color=\"red\">-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3426103\" data-linked=\"Avid Bioservices and Check-Cap among healthcare gainers; ResMed leads the losers\" data-tweet=\"$CHEK $CHEK $MRSN - Avid Bioservices and Check-Cap among healthcare gainers; ResMed leads the losers https://seekingalpha.com/news/3426103-avid-bioservices-and-check-cap-among-healthcare-gainers-resmed-leads-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3426103-avid-bioservices-and-check-cap-among-healthcare-gainers-resmed-leads-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:07 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3426102\" data-ts=\"1548432217\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VOD\" target=\"_blank\">VOD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3426102-vodafoneminus-3_2-on-tight-sales-miss-in-q3-amid-competition\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Vodafone -3.2% on tight sales miss in Q3 amid competition</a></h4><ul>   <li>Vodafone (NASDAQ:<a href='https://seekingalpha.com/symbol/VOD' title='Vodafone Group Plc'>VOD</a>) is <font color=\"red\">3.2% lower</font> this morning after narrowly missing sales estimates amid ongoing European competition in its <a href=\"https://seekingalpha.com/news/3425942-vodafone-group-reports-q3-revenue\" target=\"_blank\">Q3 report</a>.</li>    <li>Overall revenues fell 6.8% as reported; service revenues fell 3.9% to \u20ac9.79B, though they rose 0.1% on an organic basis. That just missed expectations for \u20ac9.82B.</li>    <li>Of those service revenues, Europe declined 2% to \u20ac7.496B (down 1.1% on an organic basis), while the rest of the world revenues fell 7.2% to \u20ac2.17B (but up 4.9% on an organic basis).</li>    <li>Results in Europe were similar to Q2, Vodafone says, with \"improving customer and financial trends in Italy, robust retail growth in Germany, reduced churn in Spain and a consistent performance in the UK.\"</li>    <li>\"Lower mobile contract churn across our markets and improved customer trends in Italy and Spain are encouraging, however these have not yet translated into our financial results, with a similar revenue trend in Europe to Q2,\" says CEO Nick Read.</li>    <li>He also noted emerging markets performed well except for South Africa, which was challenged by pricing cuts there.</li>    <li><a href=\"https://www.vodafone.com/content/dam/vodafone/investors/financial_results_feeds/tradingupdate-31december2018/Q3-2019-Press-Release-FINAL.pdf\" target=\"_blank\">Press release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3426102\" data-linked=\"Vodafone -3.2% on tight sales miss in Q3 amid competition\" data-tweet=\"$VOD - Vodafone -3.2% on tight sales miss in Q3 amid competition https://seekingalpha.com/news/3426102-vodafoneminus-3_2-on-tight-sales-miss-in-q3-amid-competition?source=tweet\" data-url=\"https://seekingalpha.com/news/3426102-vodafoneminus-3_2-on-tight-sales-miss-in-q3-amid-competition\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:03 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>16&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3426094\" data-ts=\"1548430969\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TESS\" target=\"_blank\">TESS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3426094-tessco-technologiesplus-7-post-q3-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tessco Technologies +7% post Q3 results</a></h4><ul><li>Tessco Technologies (<a href='https://seekingalpha.com/symbol/TESS' title='TESSCO Technologies Incorporated'>TESS</a> <font color=\"green\">+7.1%</font>) reported Q3 revenue increase of 4.1% Y/Y to $ 152.3M, with commercial market revenue +7.8% Y/Y; and retail market revenue -2.1% Y/Y.</li><li>Revenue by Products: Base Station Infrastructure $67.99M (+18.7% Y/Y); Network Systems $21.48M (-10.6% Y/Y); Installation, Test and Maintenance $8.31M (-10.3% Y/Y); and Mobile Device Accessories $54.52M (-2.1% Y/Y).</li><li>Q3 Gross margin<font color=\"green\"> improved slightly by 12 bps</font> to 20.4% and operating margin <font color=\"green\">expanded by 81 bps</font> to 2.3%.</li><li>Adj. EBITDA increased by 35.5% Y/Y to $4.65M and margin <font color=\"green\">improved by 71 bps </font>to 3.1%.</li><li>SG&amp;A expenses were $27.49M (flat Y/Y) and margin 18.1% <font color=\"green\">down 70 bps</font>.</li><li>Line of credit balance outstanding was $16.9M, compared to $5.9M a year ago.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3425789-tessco-technologies-misses-revenue\" target=\"_blank\">TESSCO Technologies misses on revenue</a> (Jan. 24).</li></ul><div class=\"tiny-share-widget\" data-id=\"3426094\" data-linked=\"Tessco Technologies +7% post Q3 results\" data-tweet=\"$TESS - Tessco Technologies +7% post Q3 results https://seekingalpha.com/news/3426094-tessco-technologiesplus-7-post-q3-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3426094-tessco-technologiesplus-7-post-q3-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:42 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3426096\" data-ts=\"1548430877\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ARNC\" target=\"_blank\">ARNC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3426096-elliott-plans-to-offer-legal-argument-to-revive-arconic-deal-ny-post\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Elliott plans to offer legal argument to revive Arconic deal - NY Post</a></h4><ul><li>Elliott Management, stunned by Arconic's (<a href='https://seekingalpha.com/symbol/ARNC' title='Arconic Inc'>ARNC</a> <font color='green'>+1.9%</font>) surprise rejection of a $10B takeover offer <a href=\"https://seekingalpha.com/news/3424570-arconic-longer-pursuing-sale-shares-26-percent\" target=\"_blank\">earlier this week</a>, is discussing a surprising legal argument in an <a href=\"https://nypost.com/2019/01/24/elliott-management-will-likely-wage-proxy-campaign-to-shake-up-arconic/\" target=\"_blank\">attempt to revive the deal</a>, <em>NY Post</em> reports.</li><li>The activist hedge fund believes ARNC rejected the bid from Apollo  Global Management partly because it did not adequately cover the  company\u2019s pension obligations, but the <em>Post</em> report cites legal experts that say the move conflicts with the law in Delaware - where ARNC is incorporated - which requires boards to focus exclusively on the  interests of shareholders.</li><li>In its rejection of Apollo\u2019s takeover bid, ARNC said it did not get an offer that was \"in the best  interests of Arconic\u2019s shareholders and other stakeholders,\" language that could provide a legal opening for a challenge from Elliott and Apollo, according to the report.</li><li>Elliott likely will wage a proxy campaign to shake up ARNC's board, <em>the Post</em> reports; the deadline to nominate directors is Feb. 15.</li></ul><div class=\"tiny-share-widget\" data-id=\"3426096\" data-linked=\"Elliott plans to offer legal argument to revive Arconic deal - NY Post\" data-tweet=\"$ARNC - Elliott plans to offer legal argument to revive Arconic deal - NY Post https://seekingalpha.com/news/3426096-elliott-plans-to-offer-legal-argument-to-revive-arconic-deal-ny-post?source=tweet\" data-url=\"https://seekingalpha.com/news/3426096-elliott-plans-to-offer-legal-argument-to-revive-arconic-deal-ny-post\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:41 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>56&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3426092\" data-ts=\"1548429935\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TWTR\" target=\"_blank\">TWTR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3426092-twitterplus-3_1-citron-reverses-stance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Twitter +3.1% as Citron reverses stance</a></h4><ul>   <li>Twitter (NYSE:<a href='https://seekingalpha.com/symbol/TWTR' title='Twitter, Inc.'>TWTR</a>) is <font color=\"green\">3.1% higher</font> just minutes after positivity from Citron Research, which says \"<a href=\"https://citronresearch.com/what-a-differene-a-month-makes-twtr-will-be-a-ok-with-aoc/\" target=\"_blank\">What a difference a month makes</a>.\"</li>    <li>The company's shares slid just a month ago as Citron referred to Twitter as the \"Harvey Weinstein of social media\" and <a href=\"https://seekingalpha.com/news/3418536-twitter-minus-8-percent-citron-mention-20-target\" target=\"_blank\">put a $20 price target</a> on.</li>    <li>In its update, Citron says \"Twitter will be A-OK because of AOC\" -- referring to freshman U.S. lawmaker Alexandria Ocasio-Cortez, making a splash due to a dominant presence on Twitter.</li>    <li>\"The 'anti-Trump' has adopted Twitter has her medium of choice and will bring a new generation of users with open minds on the platform,\" the firm says. \"More importantly, it will keep Twitter the idea leader for the next presidential election.\"</li> </ul><div class=\"tiny-share-widget\" data-id=\"3426092\" data-linked=\"Twitter +3.1% as Citron reverses stance\" data-tweet=\"$TWTR - Twitter +3.1% as Citron reverses stance https://seekingalpha.com/news/3426092-twitterplus-3_1-citron-reverses-stance?source=tweet\" data-url=\"https://seekingalpha.com/news/3426092-twitterplus-3_1-citron-reverses-stance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:25 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>40&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3426091\" data-ts=\"1548429684\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GOOS\" target=\"_blank\">GOOS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3426091-canada-gooseplus-3_7-after-evercore-defends\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Canada Goose +3.7% after Evercore defends</a></h4><ul> <li>Canada Goose (<a href='https://seekingalpha.com/symbol/GOOS' title='Canada Goose Holdings'>GOOS</a> <font color=\"green\">+3.7%</font>) rallies after Evercore ISI defends the retailer after its recent share price drop.</li> <li>The Evercore analyst team thinks that concerns of a China boycott have faded and sees the potential for significant sales growth in the region.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3426091\" data-linked=\"Canada Goose +3.7% after Evercore defends\" data-tweet=\"$GOOS - Canada Goose +3.7% after Evercore defends https://seekingalpha.com/news/3426091-canada-gooseplus-3_7-after-evercore-defends?source=tweet\" data-url=\"https://seekingalpha.com/news/3426091-canada-gooseplus-3_7-after-evercore-defends\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:21 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3426086\" data-ts=\"1548428946\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LUV\" target=\"_blank\">LUV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3426086-faa-halts-flights-laguardia\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FAA halts some flights into LaGuardia</a></h4><ul> <li>The FAA has halted some flights into LaGuardia Airport due to air traffic control staffing issues, according to CNBC. It's a development that's been building up all week amid warnings on TSA and air traffic controller staffing shortages.</li> <li>Earlier this week, Southwest CEO Gary Kelly called the government shutdown \"absolutely absurd\" without pointing a finger specifically at either political party.</li>  <li>On watch: Southwest Airlines (<a href='https://seekingalpha.com/symbol/LUV' title='Southwest Airlines Co.'>LUV</a> <font color=\"green\">+1.8%</font>), JetBlue (<a href='https://seekingalpha.com/symbol/JBLU' title='JetBlue Airways Corporation'>JBLU</a> <font color=\"green\">+0.3%</font>), Delta Air Lines (<a href='https://seekingalpha.com/symbol/DAL' title='Delta Air Lines, Inc.'>DAL</a> <font color=\"green\">+0.5%</font>), American Airlines Group (<a href='https://seekingalpha.com/symbol/AAL' title='American Airlines Group'>AAL</a> <font color=\"green\">+4.1%</font>), Alaska Air Group (<a href='https://seekingalpha.com/symbol/ALK' title='Alaska Air Group, Inc.'>ALK</a> <font color=\"red\">-2.2%</font>), Hawaiian Holdings (<a href='https://seekingalpha.com/symbol/HA' title='Hawaiian Holdings, Inc.'>HA</a> <font color=\"red\">-1.3%</font>), SkyWest (<a href='https://seekingalpha.com/symbol/SKYW' title='SkyWest, Inc.'>SKYW</a> <font color=\"green\">+1.3%</font>), Spirit Airlines (<a href='https://seekingalpha.com/symbol/SAVE' title='Spirit Airlines'>SAVE</a> <font color=\"green\">+1.1%</font>) and Allegiant Travel (<a href='https://seekingalpha.com/symbol/ALGT' title='Allegiant Travel Company'>ALGT</a> <font color=\"green\">+1%</font>).</li> </ul><div class=\"tiny-share-widget\" data-id=\"3426086\" data-linked=\"FAA halts some flights into LaGuardia\" data-tweet=\"$LUV $LUV $JBLU - FAA halts some flights into LaGuardia https://seekingalpha.com/news/3426086-faa-halts-flights-laguardia?source=tweet\" data-url=\"https://seekingalpha.com/news/3426086-faa-halts-flights-laguardia\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:09 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>68&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3426082\" data-ts=\"1548428216\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ABBV\" target=\"_blank\">ABBV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3426082-abbvie-not-see-much-growth-this-year-shares-down-7\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AbbVie does not see much growth this year; shares down 7%</a></h4><ul><li>AbbVie (<a href='https://seekingalpha.com/symbol/ABBV' title='AbbVie Inc.'>ABBV</a> <font color=\"red\">-7%</font>) is down on modestly higher volume in early trade following its <a href=\"https://seekingalpha.com/news/3426007-abbvie-3-percent-premarket-q4-miss\" target=\"_blank\">Q4 miss</a>. In the conference call, management guided only a modest ~1% rise in revenues. It expects Humira sales to grow 7% domestically but drop 30% internationally as biosimilar competition continues to heat up, expected to trim $2B off sales this year.</li><li><strong>Q1 guidance</strong>: EPS of $2.05 - 2.07 (+10% from midpoint) on revenues of $7.7B (+3%) versus consensus of $2.03 on revenues of $8.0B.</li></ul><div class=\"tiny-share-widget\" data-id=\"3426082\" data-linked=\"AbbVie does not see much growth this year; shares down 7%\" data-tweet=\"$ABBV - AbbVie does not see much growth this year; shares down 7% https://seekingalpha.com/news/3426082-abbvie-not-see-much-growth-this-year-shares-down-7?source=tweet\" data-url=\"https://seekingalpha.com/news/3426082-abbvie-not-see-much-growth-this-year-shares-down-7\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:56 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>68&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3426078\" data-ts=\"1548427847\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IBKC\" target=\"_blank\">IBKC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3426078-iberiabankplus-2_5-post-q4-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">IberiaBank +2.5% post Q4 results</a></h4><ul><li>IberiaBank (<a href='https://seekingalpha.com/symbol/IBKC' title='IBERIABANK Corporation'>IBKC</a> <font color=\"green\">+2.5%</font>) reports strong improvement in <a href=\"https://seekingalpha.com/pr/17391533-iberiabank-corporation-reports-fourth-quarter-results-achieves-2020-financial-metrics-full\" target=\"_blank\">Q4</a> GAAP and Core EPS resulting from increases in both loans and deposits resulted in the Company achieving its 2020 financial metrics in both 4Q18 and for the FY 2018.</li><li>Revenue growth and continued expense reduction produced positive operating leverage resulted in a Core Tangible Efficiency Ratio of 50.7%.</li><li>Credit metrics are strong and continue to improve with criticized, classified, and NPA were down 28% Y/Y, 30% Y/Y, and 5% Y/Y, respectively.</li><li>The allowance for loan and lease losses to total loans and leases remained flat and covered 101% of NPLs.</li><li>The Company's reported and cash net interest margins improved 7 bps and 5 bps on a linked quarter basis, to 3.81% and 3.52%, respectively.</li><li>Total loan growth of $175.9M, or 3% annualized, loan growth continues to be impacted by accelerated payoffs.</li><li>Total deposits increased $570M, or 10% annualized, total non-interest bearing deposits represented 28% of total deposits.</li><li>The Company announced a new repurchase plan of up to 2.77M shares of the Company's outstanding common stock.</li><li>During 4Q18, repurchased 1.21M common shares at a weighted average price of $72.61/share.</li><li>Also, announced a cash dividend of $0.41/common share payable on January 25, 2019.</li><li><b>2019 Guidance:</b> Average Earning Assets of $28.6B ~ $28.9B; Consolidated Loan &amp; Deposit growth rate both to be 5%-7%; Provision Expense of $42M-50M; Non-Interest Income of $215M-225M; Non-Interest expense of $685M-700M; Net Interest Margin of 3.60%-3.70% &amp; Share Repurchase activity of $135-150M.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3425977-iberiabank-beats-0_08-misses-revenue\" target=\"_blank\">IberiaBank beats by $0.08, misses on revenue</a> (Jan. 25)</li></ul><div class=\"tiny-share-widget\" data-id=\"3426078\" data-linked=\"IberiaBank +2.5% post Q4 results\" data-tweet=\"$IBKC - IberiaBank +2.5% post Q4 results https://seekingalpha.com/news/3426078-iberiabankplus-2_5-post-q4-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3426078-iberiabankplus-2_5-post-q4-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:50 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3426077\" data-ts=\"1548427606\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GWW\" target=\"_blank\">GWW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3426077-oppenheimer-stays-positive-on-w-w-grainger\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Oppenheimer stays positive on W.W. Grainger</a></h4><ul> <li>Oppenheimer checks in on W.W. Grainger (<a href='https://seekingalpha.com/symbol/GWW' title='W.W. Grainger, Inc.'>GWW</a> <font color='green'>+0.1%</font>) following the company's strong Q4 profit beat.</li> <li>After Grainger guided for full-year EPS guidance of $17.10 to $18.70 vs. $18.05 consensus, Oppenheimer lower its estimate to $18.20. The firm keeps an Outperform rating on Grainger and price target of $355 (17X FY20 EPS).</li><li>\"GWW is rapidly moving through process of transitioning some legacy go-to-market pricing models to better target certain customer segments, now regaining market share in the non-contract markets,\" notes Oppenheimer.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3425560-w-w-graingers-q4-mixed-results\" target=\"_blank\">More on W.W. Grainger's Q4 mixed results</a> (Jan. 24)</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3426077\" data-linked=\"Oppenheimer stays positive on W.W. Grainger\" data-tweet=\"$GWW - Oppenheimer stays positive on W.W. Grainger https://seekingalpha.com/news/3426077-oppenheimer-stays-positive-on-w-w-grainger?source=tweet\" data-url=\"https://seekingalpha.com/news/3426077-oppenheimer-stays-positive-on-w-w-grainger\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:46 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3426076\" data-ts=\"1548427599\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMD\" target=\"_blank\">AMD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3426076-amd-names-chief-sales-officer-cto-in-reorganization\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AMD names Chief Sales Officer, CTO in reorganization</a></h4><ul><li>AMD (NASDAQ:<a href='https://seekingalpha.com/symbol/AMD' title='Advanced Micro Devices, Inc.'>AMD</a>) <a href=\"https://seekingalpha.com/pr/17391738-amd-strengthens-senior-leadership-team\" target=\"_blank\">announces</a> a reorganization that puts all sales operations in the hands of Darren Grasby, who is appointed SVP and Chief Sales Officer.</li><li>Grasby previously led the worldwide sales to PC manufacturers and channel partners.</li><li>AMD also hires Ericsson and Blackberry vet Sandeep Chennakeshu for the new position of EVP of Computing and Graphics.</li><li>Mark Papermaster gets promoted to EVP and CTO.</li><li>Forrest Norrod, SVP and GM of data centers, will now be responsible for datacenter products across CPUs and GPUs.</li><li>AMD shares are <font color=\"green\">up 2.2%</font> to $21.30.</li></ul><div class=\"tiny-share-widget\" data-id=\"3426076\" data-linked=\"AMD names Chief Sales Officer, CTO in reorganization\" data-tweet=\"$AMD - AMD names Chief Sales Officer, CTO in reorganization https://seekingalpha.com/news/3426076-amd-names-chief-sales-officer-cto-in-reorganization?source=tweet\" data-url=\"https://seekingalpha.com/news/3426076-amd-names-chief-sales-officer-cto-in-reorganization\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:46 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>64&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3426074\" data-ts=\"1548427113\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KHRNF\" target=\"_blank\">KHRNF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3426074-khiron-enters-uruguay-cannabis-market-via-nettagrowth-buy\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Khiron enters Uruguay cannabis market via NettaGrowth buy</a></h4><ul><li>Toronto-based Khiron Life Sciences (<a href='https://seekingalpha.com/symbol/KHRNF' title='Khiron Life Sciences Corp.'>OTCQB:KHRNF</a>) has inked a binding letter <a href=\"https://seekingalpha.com/pr/17391791-khiron-life-sciences-signs-binding-loi-acquire-100-percent-nettagrowth-securing-first-medical\" target=\"_blank\">agreement </a>to acquire Vancouver-based NettaGrowth International (NettaGro) in an all-stock deal valued at ~$13.7M. Specifically, it will issue 8,498,821 common shares valued at $1.61 per share.</li><li>NettaGro owns Dormul S.A., the owner of the first license in Uruguay to produce medical cannabis there. It is apparently capable of cultivating up to 120 tons and 170K plants.</li><li>Khiron says it will be able to export medical weed from Uruguay to Southern Brazil under the Mercosur trade bloc.</li><li><strong>Update</strong>: Shares are up <font color=\"green\">13%</font> mid-session.</li></ul><div class=\"tiny-share-widget\" data-id=\"3426074\" data-linked=\"Khiron enters Uruguay cannabis market via NettaGrowth buy\" data-tweet=\"$KHRNF - Khiron enters Uruguay cannabis market via NettaGrowth buy https://seekingalpha.com/news/3426074-khiron-enters-uruguay-cannabis-market-via-nettagrowth-buy?source=tweet\" data-url=\"https://seekingalpha.com/news/3426074-khiron-enters-uruguay-cannabis-market-via-nettagrowth-buy\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:38 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>22&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3426070\" data-ts=\"1548426596\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NEE\" target=\"_blank\">NEE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3426070-nextera-energy-slides-after-q4-miss-kujawa-named-new-cfo\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">NextEra Energy slides after Q4 miss; Kujawa named new CFO</a></h4><ul><li>NextEra Energy (NYSE:<a href='https://seekingalpha.com/symbol/NEE' title='NextEra Energy, Inc.'>NEE</a>) <font color=\"red\">-1.8%</font> pre-market after both <a href=\"https://seekingalpha.com/news/3425993-nextera-energy-misses-0_04-misses-revenue\" target=\"_blank\">Q4 earnings</a> and revenues miss expectations, as the company recorded a <a href=\"https://www.marketwatch.com/story/nextera-energys-profit-dips-backs-guidance-2019-01-25\" target=\"_blank\">much smaller income tax benefit</a> and higher interest expense.</li><li>NEE says its Q4 income tax benefit totaled $25M, compared with $1.99B in the year-earlier quarter.</li><li>NEE reaffirms guidance for FY 2019, seeing adjusted EPS of $8.00-$8.50 vs. $8.40 analyst consensus estimate, and continues to expect adjusted EPS of $8.70-$9.20 in 2020 and $9.40-$9.95 in 2021.</li><li>Separately, the company names Rebecca Kujawa, current VP of business management at NextEra Energy Resources, its competitive power generation subsidiary, to succeed John Ketchum as <a href=\"https://seekingalpha.com/pr/17391667-nextera-energy-announces-organizational-changes\" target=\"_blank\">Executive VP and  CFO</a> of NextEra Energy.</li><li>Ketchum will replace Armando Pimentel, who plans to retire on March 1, as President and CEO of NextEra Energy Resources.</li></ul><div class=\"tiny-share-widget\" data-id=\"3426070\" data-linked=\"NextEra Energy slides after Q4 miss; Kujawa named new CFO\" data-tweet=\"$NEE - NextEra Energy slides after Q4 miss; Kujawa named new CFO https://seekingalpha.com/news/3426070-nextera-energy-slides-after-q4-miss-kujawa-named-new-cfo?source=tweet\" data-url=\"https://seekingalpha.com/news/3426070-nextera-energy-slides-after-q4-miss-kujawa-named-new-cfo\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:29 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3426068\" data-ts=\"1548426319\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AVYA\" target=\"_blank\">AVYA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3426068-avayaplus-5_4-barclays-sees-44-upside\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Avaya +5.4% as Barclays sees 44% upside</a></h4><ul>    <li>Avaya Holdings (NYSE:<a href='https://seekingalpha.com/symbol/AVYA' title='Avaya Holdings Corp.'>AVYA</a>) is <font color=\"green\">up 5.4%</font> premarket after a raise to Overweight at Barclays.</li>    <li>The firm's price target ticked up to $21 from $20, implying 44% upside. Analyst Raimo Lenschow noted upside in Avaya's current multiple vs. its rivals' legacy multiples.</li>    <li>Shares have <font color=\"red\">fallen 17.2%</font> over the past quarter and are <font color=\"red\">down 30.4%</font> over the past six months</li> </ul><div class=\"tiny-share-widget\" data-id=\"3426068\" data-linked=\"Avaya +5.4% as Barclays sees 44% upside\" data-tweet=\"$AVYA - Avaya +5.4% as Barclays sees 44% upside https://seekingalpha.com/news/3426068-avayaplus-5_4-barclays-sees-44-upside?source=tweet\" data-url=\"https://seekingalpha.com/news/3426068-avayaplus-5_4-barclays-sees-44-upside\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:25 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3426067\" data-ts=\"1548425997\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CRBP\" target=\"_blank\">CRBP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3426067-corbus-pharmaceuticals-prices-stock-offering-6_50-shares-down-4-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Corbus Pharmaceuticals prices stock offering at $6.50; shares down 4% premarket</a></h4><ul> <li>Corbus Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/CRBP' title='Corbus Pharmaceuticals Holdings, Inc.'>CRBP</a>) <a href=\"https://seekingalpha.com/pr/17391766-corbus-pharmaceuticals-announces-pricing-public-offering-common-stock\" target=\"_blank\">prices</a> its public offering of 5.39M common stock at a price of $6.50/share, for gross proceeds of ~$35M.</li><li>Underwriters over-allotment is an additional 808,500 shares.</li><li>Net proceeds will be used to fund clinical trials, development of lenabasum, for general corporate purposes and working capital.</li><li>Closing date is January 29.</li><li>Shares are down <font color=\"red\">4%</font> premarket.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3425805-corbus-pharma-readies-stock-offering-shares-6-percent-hours\" target=\"_blank\">Corbus Pharma readies stock offering; shares down 6% after hours</a> (Jan. 24)</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3426067\" data-linked=\"Corbus Pharmaceuticals prices stock offering at $6.50; shares down 4% premarket\" data-tweet=\"$CRBP - Corbus Pharmaceuticals prices stock offering at $6.50; shares down 4% premarket https://seekingalpha.com/news/3426067-corbus-pharmaceuticals-prices-stock-offering-6_50-shares-down-4-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3426067-corbus-pharmaceuticals-prices-stock-offering-6_50-shares-down-4-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:19 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3426065\" data-ts=\"1548425759\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RAND\" target=\"_blank\">RAND</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3426065-wdc-apto-among-premarket-gainers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">WDC, APTO among premarket gainers</a></h4><ul><li>Rand Capital (NASDAQ:<a href='https://seekingalpha.com/symbol/RAND' title='Rand Capital'>RAND</a>) <font color=\"green\">+40%</font> on <a href=\"https://seekingalpha.com/pr/17391492-rand-capital-announces-25-million-strategic-investment-east-asset-management-establishment\" target=\"_blank\">announcing</a> $25M strategic investment by east asset management and establishment of external management structure.</li><li>ClearOne (NASDAQ:<a href='https://seekingalpha.com/symbol/CLRO' title='ClearOne, Inc.'>CLRO</a>) <font color=\"green\">+25%</font> as the company <a href=\"https://seekingalpha.com/pr/17391448-clearone-prevails-shure-trial-u-s-patent-and-trademark-office\" target=\"_blank\">prevails</a> against shure in trial before the U.S. Patent &amp; Trademark Office.</li><li>Western Digital (NYSE:<a href='https://seekingalpha.com/symbol/WDC' title='Western Digital Corporation'>WDC</a>) <font color=\"green\">+10%</font> after guidance <a href=\"https://seekingalpha.com/news/3425947-western-digital-plus-8-percent-guidance-update\" target=\"_blank\">update</a>.</li><li>Aptose Biosciences (NASDAQ:<a href='https://seekingalpha.com/symbol/APTO' title='Aptose Biosciences Inc.'>APTO</a>) <font color=\"green\">+10%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3426065\" data-linked=\"WDC, APTO among premarket gainers\" data-tweet=\"$RAND $RAND $CLRO - WDC, APTO among premarket gainers https://seekingalpha.com/news/3426065-wdc-apto-among-premarket-gainers?source=tweet\" data-url=\"https://seekingalpha.com/news/3426065-wdc-apto-among-premarket-gainers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:15 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3426061\" data-ts=\"1548425527\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RMD\" target=\"_blank\">RMD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3426061-intc-and-rmd-among-premarket-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">INTC and RMD among premarket losers</a></h4><ul><li>ResMed (NYSE:<a href='https://seekingalpha.com/symbol/RMD' title='ResMed Inc.'>RMD</a>) <font color=\"red\">-14%</font> on <a href=\"https://seekingalpha.com/news/3425784-resmed-beats-0_07-misses-revenue\" target=\"_blank\">Q2 earnings</a>.</li><li>PG&amp;E (NYSE:<a href='https://seekingalpha.com/symbol/PCG' title='PG&E Corporation'>PCG</a>) <font color=\"red\">-10%</font> <a href=\"https://seekingalpha.com/news/3425757-pg-and-e-plus-25-percent-investigation-reportedly-clears-company-2017-wildfires\" target=\"_blank\">following</a> news from Cal Fire investigation.</li><li>China Lending (NASDAQ:<a href='https://seekingalpha.com/symbol/CLDC' title='China Lending Corporation'>CLDC</a>) <font color=\"red\">-9%</font>.</li><li>Intel (NASDAQ:<a href='https://seekingalpha.com/symbol/INTC' title='Intel Corporation'>INTC</a>) <font color=\"red\">-6%</font> on <a href=\"https://seekingalpha.com/news/3425767-intel-beats-0_06-misses-revenue\" target=\"_blank\">Q4 earnings</a>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3426061\" data-linked=\"INTC and RMD among premarket losers\" data-tweet=\"$RMD $RMD $PCG - INTC and RMD among premarket losers https://seekingalpha.com/news/3426061-intc-and-rmd-among-premarket-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3426061-intc-and-rmd-among-premarket-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:12 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3426058\" data-ts=\"1548425182\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ELF\" target=\"_blank\">ELF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3426058-marathon-pressure-on-e-l-f-sends-shares-up-9\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Marathon pressure on e.l.f. sends shares up 9%</a></h4><ul> <li>Stakeholder Marathon Partners Equity Management presses e.l.f. Beauty (NYSE:<a href='https://seekingalpha.com/symbol/ELF' title='e.l.f. Beauty'>ELF</a>) in a letter sent to the board to undertake a comprehensive review of the company's operating strategy, corporate governance practices and executive compensation.</li>                 <li>The recommendations from Marathon Partners include cost rationalization, corporate governance improvements and changes to executive compensation that it believes will increase shareholder value and improve potential outcomes for public shareholders.</li><li>Marathon holds a 8.6% stake in e.l.f. Beauty.</li>  <li>ELF  <font color=\"green\">+9.22%</font> premarket to  $9.00.</li><li>Source: <a href=\"https://seekingalpha.com/pr/17391685-marathon-partners-delivers-letter-e-l-f-board\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3426058\" data-linked=\"Marathon pressure on e.l.f. sends shares up 9%\" data-tweet=\"$ELF - Marathon pressure on e.l.f. sends shares up 9% https://seekingalpha.com/news/3426058-marathon-pressure-on-e-l-f-sends-shares-up-9?source=tweet\" data-url=\"https://seekingalpha.com/news/3426058-marathon-pressure-on-e-l-f-sends-shares-up-9\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:06 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3426047\" data-ts=\"1548424688\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INTC\" target=\"_blank\">INTC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3426047-susquehanna-hits-intel-sidelines-on-data-center\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Susquehanna hits Intel sidelines on data center</a></h4><ul><li>Susquehanna <a href=\"https://www.cnbc.com/2019/01/25/-chip-wrecked-intel-losing-to-competitors-heres-what-else-is-worrying-major-analysts.html\" target=\"_blank\">downgrades</a> Intel (NASDAQ:<a href='https://seekingalpha.com/symbol/INTC' title='Intel Corporation'>INTC</a>) to Neutral and drops the target by $8 to $50 after yesterday's revenue miss and downside FY revenue guidance.</li><li>The firm thinks management's FY guide for mid-single digit Y/Y Data Center growth \"implies an overly aggressive DCG acceleration in 2H19\" that Susquehanna questions given tough comps after the historic server refresh cycle and potential server share losses to AMD.</li><li>Intel shares are <font color=\"red\">down 6.3%</font> premarket to $46.64.</li></ul><div class=\"tiny-share-widget\" data-id=\"3426047\" data-linked=\"Susquehanna hits Intel sidelines on data center\" data-tweet=\"$INTC - Susquehanna hits Intel sidelines on data center https://seekingalpha.com/news/3426047-susquehanna-hits-intel-sidelines-on-data-center?source=tweet\" data-url=\"https://seekingalpha.com/news/3426047-susquehanna-hits-intel-sidelines-on-data-center\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:58 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>44&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3426040\" data-ts=\"1548423894\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NCNA\" target=\"_blank\">NCNA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3426040-nucana-withdraws-equity-offering-shares-up-15-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">NuCana withdraws equity offering; shares up 15% premarket</a></h4><ul><li>Thinly traded micro cap NuCana plc (NASDAQ:<a href='https://seekingalpha.com/symbol/NCNA' title='NuCana plc'>NCNA</a>) is up <font color=\"green\">15% </font>premarket on light volume in response to the <a href=\"https://seekingalpha.com/pr/17391638-nucana-plc-announces-withdrawal-public-offering-adss\" target=\"_blank\">withdrawal </a>of its <a href=\"https://seekingalpha.com/news/3425356-nucana-8-percent-hours-equity-offering\" target=\"_blank\">planned public offering</a> of ADSs. Management says the current market environment for a capital raise is \"not in the best interests of its shareholders.\"</li></ul><div class=\"tiny-share-widget\" data-id=\"3426040\" data-linked=\"NuCana withdraws equity offering; shares up 15% premarket\" data-tweet=\"$NCNA - NuCana withdraws equity offering; shares up 15% premarket https://seekingalpha.com/news/3426040-nucana-withdraws-equity-offering-shares-up-15-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3426040-nucana-withdraws-equity-offering-shares-up-15-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:44 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3426037\" data-ts=\"1548423623\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NVDA\" target=\"_blank\">NVDA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3426037-jefferies-removes-nvidia-from-franchise-picks\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Jefferies removes Nvidia from Franchise Picks</a></h4><ul><li>Jefferies removes Nvidia (NASDAQ:<a href='https://seekingalpha.com/symbol/NVDA' title='NVIDIA Corporation'>NVDA</a>) from its Franchise Picks list after Intel's<a href=\"https://seekingalpha.com/news/3425818-intel-minus-7-percent-downside-fy-revenue-guide\" target=\"_blank\"> earnings report</a> featured a surprise Data Center Group revenue miss.</li><li>Jefferies says it expects cloud players to digest data center capacity over the next several quarters.</li><li>Source: <a href=\"https://twitter.com/thenotablecalls\" target=\"_blank\">Notable Calls</a> and Bloomberg headline.</li><li>Nvidia shares are <font color=\"red\">down 0.5%</font> premarket to $157.</li></ul><div class=\"tiny-share-widget\" data-id=\"3426037\" data-linked=\"Jefferies removes Nvidia from Franchise Picks\" data-tweet=\"$NVDA - Jefferies removes Nvidia from Franchise Picks https://seekingalpha.com/news/3426037-jefferies-removes-nvidia-from-franchise-picks?source=tweet\" data-url=\"https://seekingalpha.com/news/3426037-jefferies-removes-nvidia-from-franchise-picks\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:40 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>18&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3426028\" data-ts=\"1548422708\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/STM\" target=\"_blank\">STM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3426028-intermonte-steps-up-to-stmicroelectronics-sidelines\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Intermonte steps up to STMicroelectronics sidelines</a></h4><ul><li>Italian investment bank Intermonte upgrades STMicroelectronics (NYSE:<a href='https://seekingalpha.com/symbol/STM' title='STMicroelectronics NV'>STM</a>) from Underperform to Neutral and raises the target from 11 euros to 15 euros. (Source: Bloomberg First Word)</li><li>STMicroelectronics <a href=\"https://seekingalpha.com/news/3425522-stmicroelectronics-plus-8_5-percent-q4-beats\" target=\"_blank\">reported</a> positive Q4 results yesterday with Q1 revenue guidance below consensus at the midpoint.</li><li>US-listed shares of STM are <font color=\"green\">up 3.2%</font> premarket to $16.12.</li></ul><div class=\"tiny-share-widget\" data-id=\"3426028\" data-linked=\"Intermonte steps up to STMicroelectronics sidelines\" data-tweet=\"$STM - Intermonte steps up to STMicroelectronics sidelines https://seekingalpha.com/news/3426028-intermonte-steps-up-to-stmicroelectronics-sidelines?source=tweet\" data-url=\"https://seekingalpha.com/news/3426028-intermonte-steps-up-to-stmicroelectronics-sidelines\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:25 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3426025\" data-ts=\"1548422464\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3426025-nasdaq-up-1-ahead-of-open\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nasdaq up more than 1% ahead of open</a></h4><ul><li>A revenue miss and <a href=\"https://seekingalpha.com/news/3425818-intel-minus-7-percent-downside-fy-revenue-guide\" target=\"_blank\">weak guidance at</a> Intel has those shares <font color=\"red\">down 6.25%</font> premarket, but Nasdaq 100 futures are up 1% one hour before the open.</li><li>Helping is an <font color=\"green\">8% advance </font>for Western Digital <a href=\"https://seekingalpha.com/news/3425947-western-digital-plus-8-percent-guidance-update\" target=\"_blank\">after issuing strong</a> forward guidance.</li><li>S&amp;P 500 and Dow futures are <font color=\"green\">up 0.75%</font>.</li><li>Asia was mostly green overnight, and Europe is up modestly at midday.</li></ul><div class=\"tiny-share-widget\" data-id=\"3426025\" data-linked=\"Nasdaq up more than 1% ahead of open\" data-tweet=\"Nasdaq up more than 1% ahead of open https://seekingalpha.com/news/3426025-nasdaq-up-1-ahead-of-open?source=tweet\" data-url=\"https://seekingalpha.com/news/3426025-nasdaq-up-1-ahead-of-open\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:21 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3426023\" data-ts=\"1548422348\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HA\" target=\"_blank\">HA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3426023-hawaiian-holdings-lower-after-deutsche-bank-cut\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Hawaiian Holdings lower after Deutsche Bank cut</a></h4><ul> <li>Shares of Hawaiian Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/HA' title='Hawaiian Holdings, Inc.'>HA</a>) slip in early trading after Deutsche Bank lowers its rating to Hold from Buy.</li> <li>The firm is the latest to warn on the impact of Southwest Airlines starting service to Hawaii and sees other \"microeconomic\" pressure on the carrier's bottom line.</li><li>DB drops its price target to $35 from $41.</li> <li>HA <font color=\"red\">-2.54%</font> premarket to $30.70 vs. a 52-week trading range of $24.81 to $44.25.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3426023\" data-linked=\"Hawaiian Holdings lower after Deutsche Bank cut\" data-tweet=\"$HA - Hawaiian Holdings lower after Deutsche Bank cut https://seekingalpha.com/news/3426023-hawaiian-holdings-lower-after-deutsche-bank-cut?source=tweet\" data-url=\"https://seekingalpha.com/news/3426023-hawaiian-holdings-lower-after-deutsche-bank-cut\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:19 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3426014\" data-ts=\"1548421466\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/APD\" target=\"_blank\">APD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3426014-air-productsminus-3-after-earnings-miss-downside-q2-earnings-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Air Products -3% after earnings miss, downside Q2 earnings guidance</a></h4><ul><li>Air Products &amp; Chemicals (NYSE:<a href='https://seekingalpha.com/symbol/APD' title='Air Products and Chemicals, Inc.'>APD</a>) <font color=\"red\">-3.2%</font> pre-market after missing expectations for <a href=\"https://seekingalpha.com/news/3425949-air-products-chemicals-misses-0_01-misses-revenue\" target=\"_blank\">FQ1 earnings</a> and guiding Q2 earnings below consensus.</li><li>APD reaffirms its FY 2019 adjusted EPS forecast of $8.05-$8.30, in line with $8.16 analyst consensus, and continues to expect capital spending of $2.3B-$2.5B for the full year, but sees EPS for the current quarter of $1.80-$1.90 vs. $1.93 consensus.</li><li>APD says Q1 adjusted EBITDA of $795M rose 8% Y/Y, driven by higher volumes, positive pricing and higher equity affiliate income; effective Oct. 1, APD adopted the new revenue recognition standard, which had no material impact on its financial statements.</li><li>Q1 sales of industrial gases in the Americas rose 9% Y/Y to $989M, sales in Europe and the Middle East gained 2% to $524M, and Asia sales fell 3% to $627M.</li></ul><div class=\"tiny-share-widget\" data-id=\"3426014\" data-linked=\"Air Products -3% after earnings miss, downside Q2 earnings guidance\" data-tweet=\"$APD - Air Products -3% after earnings miss, downside Q2 earnings guidance https://seekingalpha.com/news/3426014-air-productsminus-3-after-earnings-miss-downside-q2-earnings-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3426014-air-productsminus-3-after-earnings-miss-downside-q2-earnings-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:04 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3426013\" data-ts=\"1548421402\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CGC\" target=\"_blank\">CGC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3426013-canopy-growth-bull-hikes-price-target-shares-up-6\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Canopy Growth bull hikes price target; shares up 6%</a></h4><ul><li>Piper's Michael Lavery lifts his price target on Canopy Growth (NYSE:<a href='https://seekingalpha.com/symbol/CGC' title='Canopy Growth Corporation'>CGC</a>) to $60 from $40, suggesting <font color=\"green\">36% upside</font> from yesterday's close.</li><li>He takes note of the company's New York hemp license approval as a \"tangible first step\" in the U.S.</li><li>Shares <font color=\"green\">up 6.1%</font> premarket to $46.90.</li><li>Other names are up as well: (NASDAQ:<a href='https://seekingalpha.com/symbol/CRON' title='Cronos Group, Inc.'>CRON</a>) (<font color=\"green\">+5%</font>); (NASDAQ:<a href='https://seekingalpha.com/symbol/TLRY' title='Tilray, Inc.'>TLRY</a>) (<font color=\"green\">+3%</font>); (NASDAQ:<a href='https://seekingalpha.com/symbol/NBEV' title='New Age Beverages Corporation'>NBEV</a>) (<font color=\"green\">+2%</font>); (NYSE:<a href='https://seekingalpha.com/symbol/ACB' title='Aurora Cannabis Inc.'>ACB</a>) (<font color=\"green\">+2%</font>); (NYSE:<a href='https://seekingalpha.com/symbol/APHA' title='Aphria Inc.'>APHA</a>) (<font color=\"green\">+2%</font>).</li></ul><div class=\"tiny-share-widget\" data-id=\"3426013\" data-linked=\"Canopy Growth bull hikes price target; shares up 6%\" data-tweet=\"$CGC $CGC $CRON - Canopy Growth bull hikes price target; shares up 6% https://seekingalpha.com/news/3426013-canopy-growth-bull-hikes-price-target-shares-up-6?source=tweet\" data-url=\"https://seekingalpha.com/news/3426013-canopy-growth-bull-hikes-price-target-shares-up-6\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:03 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>58&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3426007\" data-ts=\"1548421177\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ABBV\" target=\"_blank\">ABBV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3426007-abbvie-down-3-premarket-on-q4-miss\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AbbVie down 3% premarket on Q4 miss</a></h4><ul><li>AbbVie (<a href='https://seekingalpha.com/symbol/ABBV' title='AbbVie Inc.'>ABBV</a>) <a href=\"https://seekingalpha.com/pr/17391555-abbvie-reports-full-year-fourth-quarter-2018-financial-results\" target=\"_blank\">Q4 results</a> ($M) Revenues: 8,305 (+7.3%).</li><li>Key product sales: HUMIRA: 4,918 (+0.5%); IMBRUVICA: 1,006 (+42%); Mavyret: 819; Venclexta: 124.</li><li>Net Loss: (1,826); Non-GAAP Net Income: 2,862(+19.8%); Loss Per Share: (1.23); Non-GAAP EPS: 1.90 (+28.4%).</li><li><strong>2019 Guidance</strong>: EPS: $7.39 - 7.49; Non-GAAP EPS: $8.65 - 8.75.</li><li>The consensus non-GAAP EPS and Revenue estimates for Q4 were $1.94 and $8.37B, respectively.</li><li>Shares are down <font color=\"red\">3%</font> premarket on light volume.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3425999-abbvie-misses-0_04-misses-revenue\" target=\"_blank\">AbbVie misses by $0.04, misses on revenue</a> (Jan. 25)</li><li><strong>Update</strong>: In the conference call, management guided 2019 revenue growth of ~1%. HUMIRA sales should grow 7% in the U.S. but drop 30% internationally. No large M&amp;A deals are being considered at this point. <strong>Q1 outlook</strong> is EPS of $2.05 - 2.07 on revenues of $7.7B. Current consensus is EPS of $2.03 on revenues of $8.0B.</li></ul><div class=\"tiny-share-widget\" data-id=\"3426007\" data-linked=\"AbbVie down 3% premarket on Q4 miss\" data-tweet=\"$ABBV - AbbVie down 3% premarket on Q4 miss https://seekingalpha.com/news/3426007-abbvie-down-3-premarket-on-q4-miss?source=tweet\" data-url=\"https://seekingalpha.com/news/3426007-abbvie-down-3-premarket-on-q4-miss\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:59 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>43&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3426003\" data-ts=\"1548420563\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ICLR\" target=\"_blank\">ICLR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3426003-sell-siders-cut-views-on-resmed-in-premarket-analyst-action\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sell-siders cut views on ResMed in premarket analyst action</a></h4><ul><li>ICON PLC (NASDAQ:<a href='https://seekingalpha.com/symbol/ICLR' title='Icon PLC'>ICLR</a>) upgraded to Buy with a $150 (14% upside) price target at Mizuho.</li><li>Illumina (NASDAQ:<a href='https://seekingalpha.com/symbol/ILMN' title='Illumina, Inc.'>ILMN</a>) downgraded to Hold at Deutsche Bank. Shares down <font color=\"red\">2%</font> premarket.</li><li>ResMed (NYSE:<a href='https://seekingalpha.com/symbol/RMD' title='ResMed Inc.'>RMD</a>) downgraded to Neutral at Goldman Sachs after its fiscal Q2 revenue and EPS miss. Analyst Chris Cooper cites the company's valuation and \"near-term fundamental risk\" for the downgrade. Downgraded to Underweight with a $96 (18% downside risk) price target at JPMorgan citing pricing headwinds in sleep products and software services. Jefferies also rates the stock Underperform with a Street-low price target of $75. Cheerleader Morgan Stanley stays the course with an Overweight rating although it trimmed its fair value target to $121 (3% upside) from $127. BMO has done the same, maintaining an Outperform rating while cutting the price target to $124 from $127. Shares are down <font color=\"red\">13%</font> premarket.</li></ul><div class=\"tiny-share-widget\" data-id=\"3426003\" data-linked=\"Sell-siders cut views on ResMed in premarket analyst action\" data-tweet=\"$ICLR $ICLR $ILMN - Sell-siders cut views on ResMed in premarket analyst action https://seekingalpha.com/news/3426003-sell-siders-cut-views-on-resmed-in-premarket-analyst-action?source=tweet\" data-url=\"https://seekingalpha.com/news/3426003-sell-siders-cut-views-on-resmed-in-premarket-analyst-action\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:49 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3425995\" data-ts=\"1548419744\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NEP\" target=\"_blank\">NEP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3425995-nextera-energy-partners-misses-0_81-misses-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">NextEra Energy Partners misses by $0.81, misses on revenue</a></h4><ul><li>NextEra Energy Partners (NYSEMKT:<a href='https://seekingalpha.com/symbol/NEP' title='NextEra Energy Partners, LP'>NEP</a>): Q4 GAAP EPS of -$0.39 <span style=\"color:red\">misses by $0.81</span>.</li><li>Revenue of $155M (-21.3% Y/Y) <font color=\"red\">misses by $122.74M</font>.</li><li>Shares <font color=\"green\">+1.7%</font> PM.</li><li><a href=\"https://seekingalpha.com/pr/17391543-nextera-energy-partners-lp-fourth-quarter-full-year-2018-financial-results-available\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3425995\" data-linked=\"NextEra Energy Partners misses by $0.81, misses on revenue\" data-tweet=\"$NEP - NextEra Energy Partners misses by $0.81, misses on revenue https://seekingalpha.com/news/3425995-nextera-energy-partners-misses-0_81-misses-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3425995-nextera-energy-partners-misses-0_81-misses-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:35 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3425992\" data-ts=\"1548419568\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DHI\" target=\"_blank\">DHI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3425992-d-r-horton-q1-revenue-beats-net-sales-order-value-flat\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">D.R. Horton Q1 revenue beats, net sales order value flat</a></h4><ul><li>D.R. Horton (NYSE:<a href='https://seekingalpha.com/symbol/DHI' title='D. R. Horton Inc.'>DHI</a>) <a href=\"https://seekingalpha.com/pr/17391493-d-r-horton-inc-america-s-builder-reports-fiscal-2019-first-quarter-earnings-declares\" target=\"_blank\">Q1 revenue of $3.52B</a> surpasses the average analyst estimate of $3.44B and Q1 EPS of 76 cents falls short of 78-cent estimate.</li><li>Compares with Q1 2017 revenue of $3.33B and EPS of 49 cents.</li><li>DHI <font color=\"green\">+0.5%</font> in premarket trading.</li><li>Chairman Donald R. Horton observes some \"moderation of demand for homes, particularly at higher price points.\"</li><li>Continues to see good demand and a limited supply of homes at affordable prices across its markets.</li><li>Q1 net sales orders increased 3% to 11,042 vs. 10,753 homes a year ago; net sales orders value were unchanged at $3.2B.</li><li>Q1 cancellation rate of 24% creeps up from 22% a year ago.</li><li>Had 33,700 homes in inventory at December-end and 309,400 lots owned and controlled.</li><li>Construction in progress and finished homes in inventory as of Dec. 31, 2018 was $5.84B vs. $5.09B at Sept. 30, 2018.</li><li><a href=\"http://investor.drhorton.com/\" target=\"_blank\">Conference call</a> at 8:30 AM ET.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3425965-d-r-horton-misses-0_02-beats-revenue\" target=\"_blank\">D. R. Horton misses by $0.02, beats on revenue</a> (Jan. 25)</li></ul><div class=\"tiny-share-widget\" data-id=\"3425992\" data-linked=\"D.R. Horton Q1 revenue beats, net sales order value flat\" data-tweet=\"$DHI - D.R. Horton Q1 revenue beats, net sales order value flat https://seekingalpha.com/news/3425992-d-r-horton-q1-revenue-beats-net-sales-order-value-flat?source=tweet\" data-url=\"https://seekingalpha.com/news/3425992-d-r-horton-q1-revenue-beats-net-sales-order-value-flat\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:32 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3425990\" data-ts=\"1548419385\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HSDT\" target=\"_blank\">HSDT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3425990-helius-medical-not-quite-marketing-application-for-pons-device-shares-down-6-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Helius Medical not quite there with marketing application for PoNS device; shares down 6% premarket</a></h4><ul><li>Thinly traded micro cap Helius Medical Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/HSDT' title='Helius Medical Technologies, Inc.'>HSDT</a>) slips <font color=\"red\">6%</font> premarket on light volume in reaction to its <a href=\"https://seekingalpha.com/pr/17391540-helius-medical-technologies-inc-provides-update-fda-s-review-request-de-novo-classification\" target=\"_blank\">announcement </a>that the FDA has requested additional information related to its 510(k) application under the De Novo pathway for its Portable Neuromodulation Stimulator (PoNS) device.</li><li>The review is on hold until the agency receives the requested information. The company says it will comply as soon as possible.</li></ul><div class=\"tiny-share-widget\" data-id=\"3425990\" data-linked=\"Helius Medical not quite there with marketing application for PoNS device; shares down 6% premarket\" data-tweet=\"$HSDT - Helius Medical not quite there with marketing application for PoNS device; shares down 6% premarket https://seekingalpha.com/news/3425990-helius-medical-not-quite-marketing-application-for-pons-device-shares-down-6-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3425990-helius-medical-not-quite-marketing-application-for-pons-device-shares-down-6-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:29 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3425989\" data-ts=\"1548419257\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CAMP\" target=\"_blank\">CAMP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3425989-calampplus-3-jpmorgan-leaves-sidelines\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CalAmp +3% as JPMorgan leaves sidelines</a></h4><ul><li>JPMorgan upgrades CalAmp (NASDAQ:<a href='https://seekingalpha.com/symbol/CAMP' title='CalAmp Corp.'>CAMP</a>) from Neutral to Overweight with a $17 target, a 23% upside. (Source: Bloomberg First Word)</li><li>Last month, CalAmp <a href=\"https://seekingalpha.com/news/3418663-calamp-minus-11_5-percent-q3-misses-downside-revenue-guide\" target=\"_blank\">reported</a> Q3 misses that included downside Q4 revenue guidance.</li><li>CAMP shares have pulled back <font color=\"red\">31%</font> in the past quarter and <font color=\"red\">40%</font> in the year.</li><li>CAMP is <font color=\"green\">up 3.2%</font> premarket to $14.22.</li></ul><div class=\"tiny-share-widget\" data-id=\"3425989\" data-linked=\"CalAmp +3% as JPMorgan leaves sidelines\" data-tweet=\"$CAMP - CalAmp +3% as JPMorgan leaves sidelines https://seekingalpha.com/news/3425989-calampplus-3-jpmorgan-leaves-sidelines?source=tweet\" data-url=\"https://seekingalpha.com/news/3425989-calampplus-3-jpmorgan-leaves-sidelines\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:27 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3425988\" data-ts=\"1548419089\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LEA\" target=\"_blank\">LEA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3425988-on-lear-corporations-q4-mixed-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on Lear Corporation&#39;s Q4 mixed results</a></h4><ul><li>Lear Corporation (NYSE:<a href='https://seekingalpha.com/symbol/LEA' title='Lear Corporation'>LEA</a>) <a href=\"https://seekingalpha.com/pr/17391478-lear-reports-fourth-quarter-full-year-2018-results\" target=\"_blank\">reports</a> sales dropped 5% in <a href=\"https://seekingalpha.com/pr/17391478-lear-reports-fourth-quarter-full-year-2018-results\" target=\"_blank\">Q4</a>, excluding foreign exchange impact.</li><li>Segment sales: Seating: $3.73B (-9.2%); E-Systems: $1.21B (-3.6%).</li><li>North America sales declined 5.8% to $1.84B.</li><li>Core operating margins fell 30 bps to 7.9%.</li><li>During the quarter, the company repurchased ~1.6M shares for $215M.</li><li><strong>FY2019 Guidance</strong>: Net sales: $20.9B to $21.7B; Core operating earnings: $1.6B to $1.7B; Adjusted EBITDA: $2.12B to $2.22B; Interest Expense: ~$85M; Tax rate: 22% to 23%; Adjusted net income: $1.08B to $1.17B; Restructuring costs: ~$140M; Capital spending: ~$700M; Free cash flow: $850M to $950M.</li><li>LEA <font color=\"green\">+0.70%</font> premarket.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3425948-lear-beats-0_12-misses-revenue\" target=\"_blank\">Lear beats by $0.12, misses on revenue</a> (Jan. 25)</li></ul><div class=\"tiny-share-widget\" data-id=\"3425988\" data-linked=\"More on Lear Corporation&#39;s Q4 mixed results\" data-tweet=\"$LEA - More on Lear Corporation&#39;s Q4 mixed results https://seekingalpha.com/news/3425988-on-lear-corporations-q4-mixed-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3425988-on-lear-corporations-q4-mixed-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:24 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3425973\" data-ts=\"1548417446\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CL\" target=\"_blank\">CL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3425973-colgate-palmolive-beats-0_01-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Colgate-Palmolive beats by $0.01, beats on revenue</a></h4><ul><li>Colgate-Palmolive (NYSE:<a href='https://seekingalpha.com/symbol/CL' title='Colgate-Palmolive Co.'>CL</a>): Q4 Non-GAAP EPS of $0.74 <span style=\"color:green\">beats by $0.01</span>; GAAP EPS of $0.70 <span style=\"color:red\">misses by $0.03</span>.</li><li>Revenue of $3.81B (-2.1% Y/Y) <font color=\"green\">beats by $30M</font>.</li><li>Shares <font color=\"green\">+1.33%</font> PM.</li><li><a href=\"https://seekingalpha.com/pr/17391502-colgate-announces-4th-quarter-2018-results\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3425973\" data-linked=\"Colgate-Palmolive beats by $0.01, beats on revenue\" data-tweet=\"$CL - Colgate-Palmolive beats by $0.01, beats on revenue https://seekingalpha.com/news/3425973-colgate-palmolive-beats-0_01-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3425973-colgate-palmolive-beats-0_01-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:57 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3425947\" data-ts=\"1548414079\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WDC\" target=\"_blank\">WDC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3425947-western-digitalplus-8-after-guidance-update\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Western Digital +8% after guidance update</a></h4><ul> <li>Western Digital (NYSE:<a href='https://seekingalpha.com/symbol/WDC' title='Western Digital Corporation'>WDC</a>) reverses an initial post-earnings drop after the company issues FQ3 guidance on its conference call.</li> <li>WDC expects FQ3 revenue of $3.6B to $3.8B and EPS of $0.40 to $0.60.</li> <li>Gross margin of approximately 28% is anticipated and operating expenses are seen landing in a range of $760M to $780M.</li> <li><a href=\"https://seekingalpha.com/article/4235526-western-digital-corporation-wdc-ceo-steve-milligan-q2-2019-results-earnings-call-transcript\" target=\"_blank\">WDC earnings call transcript</a></li><li>Shares of WDC are <font color=\"green\">up 8.40%</font> in premarket trading.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3425834-western-digital-minus-4-percent-q2-misses\" target=\"_blank\">Western Digital -4% on Q2 misses</a> (Jan. 24)</li></ul><div class=\"tiny-share-widget\" data-id=\"3425947\" data-linked=\"Western Digital +8% after guidance update\" data-tweet=\"$WDC - Western Digital +8% after guidance update https://seekingalpha.com/news/3425947-western-digitalplus-8-after-guidance-update?source=tweet\" data-url=\"https://seekingalpha.com/news/3425947-western-digitalplus-8-after-guidance-update\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:01 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3425941\" data-ts=\"1548413262\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GWLLF\" target=\"_blank\">GWLLF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3425941-great-wall-motor-rallies-after-update\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Great Wall Motor rallies after update</a></h4><ul> <li>Great Wall Motor (<a href='https://seekingalpha.com/symbol/GWLLF' title='Great Wall Motor Company, Ltd.'>OTCPK:GWLLF</a>, <a href='https://seekingalpha.com/symbol/GWLLY' title='Great Wall Motor Company, Ltd. ADR'>OTCPK:GWLLY</a>) increases its 2019 sales target to 1.20M units from a target of 1.16M units in 2018, according to a <a href=\"http://www.gwm-global.com/investor-relations/announcement.html\" target=\"_blank\">new filing</a> by the company.</li> <li>Shares of Great Wall closed <font color=\"green\">up 3.75%</font> in Hong Kong after the company reported operating revenue of 97B yuan for the full year.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3425941\" data-linked=\"Great Wall Motor rallies after update\" data-tweet=\"$GWLLF $GWLLF $GWLLY - Great Wall Motor rallies after update https://seekingalpha.com/news/3425941-great-wall-motor-rallies-after-update?source=tweet\" data-url=\"https://seekingalpha.com/news/3425941-great-wall-motor-rallies-after-update\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:47 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3425937\" data-ts=\"1548412168\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TCEHY\" target=\"_blank\">TCEHY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3425937-tencentplus-3-after-landing-mobile-game-approval-in-china\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tencent +3% after landing mobile game approval in China</a></h4><ul><li>Chinese regulators approved two mobile games from Tencent Holdings (<a href='https://seekingalpha.com/symbol/TCEHY' title='Tencent Holding Ltd. ADR'>OTCPK:TCEHY</a>, <a href='https://seekingalpha.com/symbol/TCTZF' title='Tencent Holding Ltd.'>OTCPK:TCTZF</a>) to mark the first approval since a freeze on new approvals was imposed in March amid increased scrutiny of the sector.</li><li>The State Administration of Press, Publication, Radio, Film and Television approved a total of 95 games in its fourth list since December.</li><li>Shares of Tencent <font color=\"green\">rallied more than 3%</font> in Hong Kong trading off the development.</li></ul><div class=\"tiny-share-widget\" data-id=\"3425937\" data-linked=\"Tencent +3% after landing mobile game approval in China\" data-tweet=\"$TCEHY $TCEHY $TCTZF - Tencent +3% after landing mobile game approval in China https://seekingalpha.com/news/3425937-tencentplus-3-after-landing-mobile-game-approval-in-china?source=tweet\" data-url=\"https://seekingalpha.com/news/3425937-tencentplus-3-after-landing-mobile-game-approval-in-china\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:29 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":71,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}